Altek - Audit Report / Information 2025

ALTEK CORPORATION

PARENT COMPANY ONLY FINANCIAL

STATEMENTS AND INDEPENDENT AUDITORS’

REPORT

DECEMBER 31, 2025 AND 2024 (Stock Code ： 3059)

For the convenience of readers and for information purpose only, the auditors’ report and the accompanying financial statements have been translated into English from the original Chinese version prepared and used in the Republic of China. In the event of any discrepancy between the English version and the original Chinese version or any differences in the interpretation of the two versions, the Chinese-language auditors’ report and financial statements shall prevail.

~1~

INDEPENDENT AUDITORS’ REPORT TRANSLATED FROM CHINESE

PWCR25000404

To the Board of Directors and Shareholders of ALTEK CORPORATION

Opinion

We have audited the accompanying parent company only balance sheets of ALTEK CORPORATION as of December 31, 2025 and 2024, and the related parent company only statements of comprehensive income, of changes in equity and of cash flows for the years then ended, and the notes to the parent company only financial statements, including a summary of material accounting policies.

In our opinion, the accompanying parent company only financial statements present fairly, in all material respects, the financial position of ALTEK CORPORATION as of December 31, 2025 and 2024, and its financial performance and its cash flows for the years then ended in accordance with the Regulations Governing the Preparation of Financial Reports by Securities Issuers and the International Financial Reporting Standards, International Accounting Standards, IFRIC Interpretations, and SIC Interpretations that came into effect as endorsed by the Financial Supervisory Commission.

~2~

Basis for opinion

We conducted our audits in accordance with the Regulations Governing Financial Statement Audit and Attestation Engagements of Certified Public Accountants and Standards on Auditing of the Republic of China. Our responsibilities under those standards are further described in the Auditors’ Responsibilities for the Audit of the Parent Company Only Financial Statements section of our report. We are independent of ALTEK CORPORATION in accordance with the Norm of Professional Ethics for Certified Public Accountants of the Republic of China, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Key audit matters

Key audit matters are those matters that, in our professional judgment, were of most significance in our audit of ALTEK CORPORATION’s 2025 parent company only financial statements of the current period. These matters were addressed in the context of our audit of the parent company only financial statements as a whole and, in forming our opinion thereon, we do not provide a separate opinion on these matters.

Key audit matters for ALTEK CORPORATION’s 2025 parent company only financial statements of the current period are stated as follows:

Allowance for inventory valuation losses

Description

Please refer to Note 4(12) for description of accounting policy on inventory valuation. Please refer to Note 5(2) for accounting estimates and assumption uncertainty in relation to inventory valuation. Please refer to Note 6(5) for the details of inventories.

~3~

ALTEK CORPORATION and its subsidiaries (shown as Investments accounted for under the equity method) are primarily engaged in manufacturing and sales of AI image‑related application products. The subsidiaries measure inventories sold at the lower of cost and net realisable value. For inventory that is over a certain age and individually identified obsolete or damaged inventory, the subsidiaries recognises losses at net realisable value. The value of inventories is significant, involves various types of inventory, and the individual identification of inventory usually involves management judgement which is an area that also needs to be assessed using our judgement during the audit process. Thus, we identified the subsidiaries’ valuation of allowance for inventory losses as one of the key audit matters.

How our audit addressed the matter

We performed the following audit procedures on the above key audit matter:

A. Obtained an understanding and assessed the provision policy on inventory valuation losses, and ensured consistent application of accounting policies.
B. Obtained the statement of individually identified obsolete inventory prepared by management and checked the accuracy of stock age analysis report and relevant information.
C. Checked the accuracy of net realisable value of inventory, assessed the consistency between valuation of market value decline and its provision policy, and assessed the reasonableness of allowance for valuation losses determined by the Company.

~4~

Responsibilities of management and those charged with governance for the parent company only financial statements

Management is responsible for the preparation and fair presentation of the parent company only financial statements in accordance with the Regulations Governing the Preparation of Financial Reports by Securities Issuers and the International Financial Reporting Standards, International Accounting Standards, IFRIC Interpretations, and SIC Interpretations that came into effect as endorsed by the Financial Supervisory Commission, and for such internal controls as management determines are necessary to enable the preparation of parent company only financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the parent company only financial statements, management is responsible for assessing ALTEK CORPORATION’s ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless management either intends to liquidate ALTEK CORPORATION or to cease operations, or has no realistic alternative but to do so.

Those charged with governance, including the audit committee, are responsible for overseeing ALTEK CORPORATION’s financial reporting process.

~5~

Auditor’s responsibilities for the audit of the parent company only financial

statements

Our objectives are to obtain reasonable assurance about whether the parent company only financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditors’ report that includes our opinion. Reasonable assurance is a high level of assurance, but it is not a guarantee that an audit conducted in accordance with Standards of Auditing of the Republic of China will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these parent company only financial statements.

As part of an audit in accordance with Standards of Auditing of the Republic of China, we exercise professional judgment and professional skepticism throughout the audit. We also:

A. Identify and assess the risks of material misstatement of the parent company only financial statements, whether due to fraud or error, design and perform audit procedures responsive to those risks, and obtain audit evidence that is sufficient and appropriate to provide a basis for our opinion. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal controls.
B. Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of ALTEK CORPORATION’s internal controls.
C. Evaluate the appropriateness of accounting policies used and the reasonableness of accounting estimates and related disclosures made by management.

~6~

D. Conclude on the appropriateness of management’s use of the going concern basis of accounting and, based on the audit evidence obtained, whether a material uncertainty exists related to events or conditions that may cast significant doubt on ALTEK CORPORATION’s ability to continue as a going concern. If we conclude that a material uncertainty exists, we are required to draw attention in our auditors’ report to the related disclosures in the parent company only financial statements or, if such disclosures are inadequate, to modify our opinion. Our conclusions are based on the audit evidence obtained up to the date of our auditors’ report. However, future events or conditions may cause ALTEK CORPORATION to cease to continue as a going concern.
E. Evaluate the overall presentation, structure and content of the parent company only financial statements, including the disclosures, and whether the parent company only financial statements represent the underlying transactions and events in a manner that achieves fair presentation.
F. Obtain sufficient appropriate audit evidence regarding the financial information of the entities or business activities within ALTEK CORPORATION to express an opinion on the parent company only financial statements. We are responsible for the direction, supervision and performance of ALTEK CORPORATION’s audit. We remain solely responsible for our audit opinion.

We communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit and significant audit findings, including any significant deficiencies in internal control that we identify during our audit.

We also provide those charged with governance with a statement that we have complied with relevant ethical requirements regarding independence, and to communicate with them all relationships and other matters that may reasonably be thought to bear on our independence, and where applicable, related safeguards.

~7~

From the matters communicated with those charged with governance, we determine those matters that were of most significance in the audit of the parent company only financial statements of the current period and are therefore the key audit matters. We describe these matters in our auditors’ report unless law or regulation precludes public disclosure about the matter or when, in extremely rare circumstances, we determine that a matter should not be communicated in our report because the adverse consequences of doing so would reasonably be expected to outweigh the public interest benefits of such communication.

Chiang, Tsai-Yen For and on behalf of PricewaterhouseCoopers, Taiwan March 11, 2026

[Hsieh, Chih-Cheng ]

The accompanying parent company only financial statements are not intended to present the financial position and results of operations and cash flows in accordance with accounting principles generally accepted in countries and jurisdictions other than the Republic of China. The standards, procedures and practices in the Republic of China governing the audit of such financial statements may differ from those generally accepted in countries and jurisdictions other than the Republic of China. Accordingly, the accompanying parent company only financial statements and independent auditors’ report are not intended for use by those who are not informed about the accounting principles or auditing standards generally accepted in the Republic of China, and their applications in practice.

As the financial statements are the responsibility of the management, PricewaterhouseCoopers cannot accept any liability for the use of, or reliance on, the English translation or for any errors or misunderstandings that may derive from the translation.

~8~

ALTEK CORPORATION

PARENT COMPANY ONLY BALANCE SHEETS DECEMBER 31, 2025 AND 2024

(Expressed in thousands of New Taiwan dollars)

Assets	December 31, 2024	December 31, 2024
	AMOUNT `$` `1,105,899` `391,106` `20,680` `5,174` `39,463` `25,236` `91,404` `16,840` `1,695,802` `80,511` `-` `11,312,137` `888,889` `80,585` `729,449` `3,678` `13,844` `39,116` `13,148,209` `$` `14,844,011`	%
Current assets 1100 Cash and cash equivalents 1170 Accounts receivable, net 1180 Accounts receivable - related parties 1200 Other receivables 1210 Other receivables - related parties 1220 Current income tax assets 130X Inventories, net 1410 Prepayments 11XX Current Assets Non-current assets 1510 Non-current financial assets at fair value through profit or loss 1517 Non-current financial assets at fair value through other comprehensive income 1550 Investments accounted for under the equity method 1600 Property, plant and equipment 1755 Right-of-use assets 1760 Investment property - net 1780 Intangible assets 1840 Deferred income tax assets 1900 Other non-current assets 15XX Non-current assets 1XXX Total assets		`7` `3` `-` `-` `-` `-` `1` `-`
		`11`
		`1` `-` `76` `6` `1` `5` `-` `-` `-`
		`89`
		`100`

~9~

ALTEK CORPORATION

PARENT COMPANY ONLY BALANCE SHEETS DECEMBER 31, 2025 AND 2024

(Expressed in thousands of New Taiwan dollars)

Liabilities and Equity December 31, 2025
December 31, 2024
Notes
AMOUNT
%
AMOUNT
%
6(11)
$
1,850,000
14
$
1,870,000
13
6(20)
64,572
1
138,102
1
36,084
-
41,143
-
7
565,488
4
697,040
5
378,246
3
364,523
3
7
3,846
-
5,343
-
7,999
-
5,990
-
6(15)
51,735
-
49,482
-
4,217
-
4,537
-
24,047
-
36,960
-
2,986,234
22
3,213,120
22
6(12) and 8
176,400
1
900,000
6
6(27)
488,611
4
488,513
3
74,170
1
78,803
1
64,933
-
65,617
-
804,114
6
1,532,933
10
3,790,348
28
4,746,053
32
6(16)
3,072,420
22
3,058,000
21
6(17)
2,586,876
19
2,542,903
17
6(18)
1,545,167
11
1,512,604
10
182,626
1
624,316
4
2,964,042
22
2,580,010
17
6(19)
(
360,269) (
3) (
181,774) (
1 )
6(16)
(
2,847)
- (
38,101)
-
9,988,015
72
10,097,958
68
11
$
13,778,363
100
$
14,844,011
100

Current liabilities
2100
Short-term borrowings
2130
Current contract liabilities
2170
Accounts payable
2180
Accounts payable - related parties
2200
Other payables
2220
Other payables - related parties
2230
Current income tax liabilities
2250
Provisions for liabilities - current
2280
Current lease liabilities
2399
Other current liabilities, others
21XX
Current Liabilities
Non-current liabilities
2540
Long-term borrowings
2570
Deferred income tax liabilities
2580
Non-current lease liabilities
2600
Other non-current liabilities
25XX
Non-current liabilities
2XXX
Total Liabilities
Equity
Share capital
3110
Common stock
Capital surplus
3200
Capital surplus
Retained earnings
3310
Legal reserve
3320
Special reserve
3350
Unappropriated retained earnings
Other equity interest
3400
Other equity interest
3500
Treasury stocks
3XXX
Total equity
Significant events after the balance
sheet date
3X2X
Total liabilities and equity

Liabilities and Equity	December 31, 2025 December 31, 2024 Notes AMOUNT % AMOUNT % 6(11) `$` `1,850,000` `14` `$` `1,870,000` `13` 6(20) `64,572` `1` `138,102` `1` `36,084` `-` `41,143` `-` 7 `565,488` `4` `697,040` `5` `378,246` `3` `364,523` `3` 7 `3,846` `-` `5,343` `-` `7,999` `-` `5,990` `-` 6(15) `51,735` `-` `49,482` `-` `4,217` `-` `4,537` `-` `24,047` `-` `36,960` `-` `2,986,234` `22` `3,213,120` `22` 6(12) and 8 `176,400` `1` `900,000` `6` 6(27) `488,611` `4` `488,513` `3` `74,170` `1` `78,803` `1` `64,933` `-` `65,617` `-` `804,114` `6` `1,532,933` `10` `3,790,348` `28` `4,746,053` `32` 6(16) `3,072,420` `22` `3,058,000` `21` 6(17) `2,586,876` `19` `2,542,903` `17` 6(18) `1,545,167` `11` `1,512,604` `10` `182,626` `1` `624,316` `4` `2,964,042` `22` `2,580,010` `17` 6(19) `(` `360,269) (` `3) (` `181,774) (` `1 )` 6(16) `(` `2,847)` `- (` `38,101)` `-` `9,988,015` `72` `10,097,958` `68` 11 `$` `13,778,363` `100` `$` `14,844,011` `100`
Current liabilities 2100 Short-term borrowings 2130 Current contract liabilities 2170 Accounts payable 2180 Accounts payable - related parties 2200 Other payables 2220 Other payables - related parties 2230 Current income tax liabilities 2250 Provisions for liabilities - current 2280 Current lease liabilities 2399 Other current liabilities, others 21XX Current Liabilities Non-current liabilities 2540 Long-term borrowings 2570 Deferred income tax liabilities 2580 Non-current lease liabilities 2600 Other non-current liabilities 25XX Non-current liabilities 2XXX Total Liabilities Equity Share capital 3110 Common stock Capital surplus 3200 Capital surplus Retained earnings 3310 Legal reserve 3320 Special reserve 3350 Unappropriated retained earnings Other equity interest 3400 Other equity interest 3500 Treasury stocks 3XXX Total equity Significant events after the balance sheet date 3X2X Total liabilities and equity

The accompanying notes are an integral part of these parent company only financial statements.

~10~

ALTEK CORPORATION

PARENT COMPANY ONLY STATEMENTS OF COMPREHENSIVE INCOME YEARS ENDED DECEMBER 31, 2025 AND 2024

(Expressed in thousands of New Taiwan dollars, except earnings per share amount)

Items Year ended December 31
2025
2024
Notes
AMOUNT
%
AMOUNT
%
6(20) and 7
$
3,007,608
100
$
2,764,952
100
6(5)(25)(26) and 7
(
2,657,399) (
88) (
2,332,466) (
84)
350,209
12
432,486
16
6(25)(26) and 7
(
50,261) (
2) (
39,988) (
1)
(
237,696) (
8) (
239,604) (
9)
(
340,672) (
11) (
396,956) (
14)
12(2)
2
-
275
-
(
628,627) (
21) (
676,273) (
24)
(
278,418) (
9) (
243,787) (
8)
6(21)
2,673
-
3,008
-
6(22) and 7
32,741
1
29,517
1
6(23)
3,034
-
242
-
6(24)
(
41,110) (
1) (
50,233) (
2)
6(6)
670,555
22
599,332
22
667,893
22
581,866
21
389,475
13
338,079
13
6(27)
(
11,814)
-
(
20,074) (
1)
$
377,661
13
$
318,005
12
6(13)
$
4,057
-
$
9,523
-
(
19,248) (
1) (
3,582)
-
6(27)
(
812)
-
(
1,905)
-
(
16,003) (
1)
4,036
-
(
252,585) (
9)
557,655
20
6(27)
50,517
2
(
111,531) (
4)
(
202,068) (
7)
446,124
16
($
218,071) (
8) $
450,160
16
$
159,590
5
$
768,165
28
6(28)
$
1.24
$
1.15
6(28)
$
1.23
$
1.13

4000
Operating revenue
5000
Operating costs
5900
Net operating margin
Operating expenses
6100
Selling expenses
6200
General and administrative expenses
6300
Research and development expenses
6450
Expected credit gains
6000
Total operating expenses
6900
Operating loss
Non-operating income and expenses
7100
Interest income
7010
Other income
7020
Other gains and losses
7050
Finance costs
7070
Share of profit of associates and joint
ventures accounted for using equity
method, net
7000
Total non-operating income and
expenses
7900
Profit before income tax
7950
Income tax expense
8200
Profit for the year
Other comprehensive income
Components of other comprehensive
income (loss) that will not be reclassified
to profit or loss
8311
Other comprehensive income, before tax,
actuarial gains on defined benefit plans
8330
Share of other comprehensive income of
associates and joint ventures accounted
for using equity method, components of
other comprehensive income that will not
be reclassified to profit or loss
8349
Income tax related to components of
other comprehensive income that will not
be reclassified to profit or loss
8310
Components of other comprehensive
income that will not be reclassified to
profit or loss
Components of other comprehensive
(loss) income that may be reclassified to
profit or loss
8361
Other comprehensive (loss) income,
before tax, exchange differences on
translation
8399
Income tax relating to components of
other comprehensive income
8360
Components of other comprehensive
(loss) income that may be reclassified
to profit or loss
8300
Other comprehensive (loss) income for
the year
8500
Total comprehensive income for the year
9750
Basic earnings per share
9850
Diluted earnings per share

Items	Year ended December 31 2025 2024 Notes AMOUNT % AMOUNT % 6(20) and 7 `$` `3,007,608` `100` `$` `2,764,952` `100` 6(5)(25)(26) and 7 `(` `2,657,399) (` `88) (` `2,332,466) (` `84)` `350,209` `12` `432,486` `16` 6(25)(26) and 7 `(` `50,261) (` `2) (` `39,988) (` `1)` `(` `237,696) (` `8) (` `239,604) (` `9)` `(` `340,672) (` `11) (` `396,956) (` `14)` 12(2) `2` `-` `275` `-` `(` `628,627) (` `21) (` `676,273) (` `24)` `(` `278,418) (` `9) (` `243,787) (` `8)` 6(21) `2,673` `-` `3,008` `-` 6(22) and 7 `32,741` `1` `29,517` `1` 6(23) `3,034` `-` `242` `-` 6(24) `(` `41,110) (` `1) (` `50,233) (` `2)` 6(6) `670,555` `22` `599,332` `22` `667,893` `22` `581,866` `21` `389,475` `13` `338,079` `13` 6(27) `(` `11,814)` `-` `(` `20,074) (` `1)` `$` `377,661` `13` `$` `318,005` `12` 6(13) `$` `4,057` `-` `$` `9,523` `-` `(` `19,248) (` `1) (` `3,582)` `-` 6(27) `(` `812)` `-` `(` `1,905)` `-` `(` `16,003) (` `1)` `4,036` `-` `(` `252,585) (` `9)` `557,655` `20` 6(27) `50,517` `2` `(` `111,531) (` `4)` `(` `202,068) (` `7)` `446,124` `16` `($` `218,071) (` `8) $` `450,160` `16` `$` `159,590` `5` `$` `768,165` `28` 6(28) `$` `1.24` `$` `1.15` 6(28) `$` `1.23` `$` `1.13`
4000 Operating revenue 5000 Operating costs 5900 Net operating margin Operating expenses 6100 Selling expenses 6200 General and administrative expenses 6300 Research and development expenses 6450 Expected credit gains 6000 Total operating expenses 6900 Operating loss Non-operating income and expenses 7100 Interest income 7010 Other income 7020 Other gains and losses 7050 Finance costs 7070 Share of profit of associates and joint ventures accounted for using equity method, net 7000 Total non-operating income and expenses 7900 Profit before income tax 7950 Income tax expense 8200 Profit for the year Other comprehensive income Components of other comprehensive income (loss) that will not be reclassified to profit or loss 8311 Other comprehensive income, before tax, actuarial gains on defined benefit plans 8330 Share of other comprehensive income of associates and joint ventures accounted for using equity method, components of other comprehensive income that will not be reclassified to profit or loss 8349 Income tax related to components of other comprehensive income that will not be reclassified to profit or loss 8310 Components of other comprehensive income that will not be reclassified to profit or loss Components of other comprehensive (loss) income that may be reclassified to profit or loss 8361 Other comprehensive (loss) income, before tax, exchange differences on translation 8399 Income tax relating to components of other comprehensive income 8360 Components of other comprehensive (loss) income that may be reclassified to profit or loss 8300 Other comprehensive (loss) income for the year 8500 Total comprehensive income for the year 9750 Basic earnings per share 9850 Diluted earnings per share

The accompanying notes are an integral part of these parent company only financial statements.

~11~

ALTEK CORPORATION

PARENT COMPANY ONLY STATEMENTS OF CHANGES IN EQUITY YEARS ENDED DECEMBER 31, 2025 AND 2024

(Expressed in thousands of New Taiwan dollars)

2024 Balance at January 1, 2024 Profit for the year Other comprehensive income (loss) for the year Total comprehensive income (loss) Appropriation of 2023 earnings Legal reserve Special reserve Cash dividends Cash capital increase Share-based payment transactions Changes in ownership interest in subsidiaries Balance at December 31, 2024 2025 Balance at January 1, 2025 Profit for the year Other comprehensive income (loss) for the year Total comprehensive income (loss) Appropriation of 2024 earnings Legal reserve Reversal of special reserve Cash dividends Restricted stocks to employees Retirement of treasury share Treasury stock transferred to employees Share-based payment transactions Changes in ownership interests in subsidiaries Treasury shares repurchased Proceeds from disposal of financial assets at fair value through other comprehensive income Balance at December 31, 2025	Notes		Common stock		Capital surplus				Retained Earnings	Retained Earnings					Other equityinterest				Treasurystocks		Total equity
							Legal reserve		Special reserve		Unappropriated retained earnings	Currency translation differences of foreign operations			Unrealised gains (losses) from financial assets measured at fair value through other comprehensive income		Unearned compensation
	6(19) 6(18) 6(16)(17) 6(14)(17) 6(17) 6(19) 6(18) 6(16)(17)(19) 6(16)(17) 6(16)(17) 6(14)(19) 6(17) 6(16) 6(19)		`$ 2,788,000` `-` `-` `-` `-` `-` `-` `270,000` `-` `-` `$ 3,058,000` `$ 3,058,000` `-` `-` `-` `-` `-` `-` `14,950` `(` `530` `)` `-` `-` `-` `-` `-` `$ 3,072,420`		`$ 2,046,394` `-` `-` `-` `-` `-` `-` `449,154` `38,970` `8,385` `$ 2,542,903` `$ 2,542,903` `-` `-` `-` `-` `-` `-` `52,848` `(` `435 )` `(` `92 )` `-` `(` `8,348 )` `-` `-` `$ 2,586,876`		`$ 1,484,678` `-` `-` `-` `27,926` `-` `-` `-` `-` `-` `$ 1,512,604` `$ 1,512,604` `-` `-` `-` `32,563` `-` `-` `-` `-` `-` `-` `-` `-` `-` `$ 1,545,167`		`$` `515,412` `-` `-` `-` `-` `108,904` `-` `-` `-` `-` `$` `624,316` `$` `624,316` `-` `-` `-` `-` `(` `441,690` `)` `-` `-` `-` `-` `-` `-` `-` `-` `$` `182,626`		`$` `2,584,914` `318,005` `7,618` `325,623` `(` `27,926 )` `(` `108,904 )` `(` `193,697 )` `-` `-` `-` `$` `2,580,010` `$` `2,580,010` `377,661` `3,245` `380,906` `(` `32,563 )` `441,690` `(` `305,647 )` `-` `-` `-` `-` `(` `10,922 )` `-` `(` `89,432 )` `$` `2,964,042`		`($` `445,272 )` `-` `446,124` `446,124` `-` `-` `-` `-` `-` `-` `$` `852` `$` `852` `-` `(` `202,068 )` `(` `202,068 )` `-` `-` `-` `-` `-` `-` `-` `-` `-` `-` `($` `201,216 )`		`($` `179,044` `)` `-` `(` `3,582` `)` `(` `3,582` `)` `-` `-` `-` `-` `-` `-` `($` `182,626` `)` `($` `182,626` `)` `-` `(` `19,248` `)` `(` `19,248` `)` `-` `-` `-` `-` `-` `-` `-` `-` `-` `89,432` `($` `112,442` `)`		`$` `-` `-` `-` `-` `-` `-` `-` `-` `-` `-` `$` `-` `$` `-` `-` `-` `-` `-` `-` `-` `(` `67,798 )` `-` `-` `21,187` `-` `-` `-` `($` `46,611 )`		`($` `38,101` `)` `-` `-` `-` `-` `-` `-` `-` `-` `-` `($` `38,101` `)` `($` `38,101` `)` `-` `-` `-` `-` `-` `-` `-` `965` `37,136` `-` `-` `(` `2,847` `)` `-` `($` `2,847` `)`		`$ 8,756,981` `318,005` `450,160` `768,165` `-` `-` `(` `193,697 )` `719,154` `38,970` `8,385` `$ 10,097,958` `$ 10,097,958` `377,661` `(` `218,071 )` `159,590` `-` `-` `(` `305,647 )` `-` `-` `37,044` `21,187` `(` `19,270 )` `(` `2,847 )` `-` `$ 9,988,015`

The accompanying notes are an integral part of these parent company only financial statements.

~12~

ALTEK CORPORATION

PARENT COMPANY ONLY STATEMENTS OF CASH FLOWS YEARS ENDED DECEMBER 31, 2025 AND 2024

(Expressed in thousands of New Taiwan dollars)

CASH FLOWS FROM OPERATING ACTIVITIES
Profit before tax
Adjustments
Adjustments to reconcile profit (loss)
Depreciation

Amortization

Expected credit gains

Net gain on financial assets at fair value through
profit

Interest expense

Interest income

Dividend income

Share-based payment compensation cost

Profit on investments accounted for under the
equity method

Gain arising from lease modification

Changes in operating assets and liabilities
Changes in operating assets
Accounts receivable
Accounts receivable-related parties
Other receivables
Other receivables-related parties
Inventories
Prepayments
Other current assets
Changes in operating liabilities
Contract liabilities
Accounts payable
Accounts payable - related parties
Other payables
Other payables-related parties
Provision of liabilities
Other current liabilities
Other non-current liabilities
Cash (outflow) inflow generated from operations
Interest received
Dividend received

Interest paid
Income tax paid
Net cash flows from operating activities Year ended December 31
Notes
2025
2024
$
389,475 $
338,079
6(7)(8)(9)(25)
44,732
46,086
6(10)(25)
5,807
3,888
12(2)
(
2 ) (
275 )
6(2)(23)
8,317
9,278
6(24)
41,110
50,233
6(21)
(
2,673 ) (
3,008 )
6(22)
(
3,814 ) (
3,052 )
6(14)
10,657
17,626
6(6)
(
670,555 ) (
599,332 )
6(23)
(
2,756 )
-
8,849
486,221
19,498 (
20,678 )
(
2,370 )
1,666
8,779
27,557
41,207
7,774
2,778 (
8,608 )
-
156
(
73,530 ) (
262 )
(
5,059 ) (
70,816 )
(
131,552 ) (
28,222 )
16,065
4,636
(
1,497 ) (
5,426 )
2,253 (
26,595 )
(
12,913 )
4,621
(
602 ) (
7,195 )

(
307,796 )
224,352
2,632
3,008
7
726,664
290,558
(
41,695 ) (
48,080 )
(
1,559 ) (
130,192 )
378,246
339,646

(Continued)

~13~

ALTEK CORPORATION

PARENT COMPANY ONLY STATEMENTS OF CASH FLOWS YEARS ENDED DECEMBER 31, 2025 AND 2024

(Expressed in thousands of New Taiwan dollars)

CASH FLOWS FROM INVESTING ACTIVITIES
Acquisition of property, plant, and equipment

Proceeds from disposal of property, plant and
equipment
Acquisition of intangible assets

Decrease in guarantee deposits paid
Net cash flows used in investing activities
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from short-term borrowings

Repayment of short-term borrowings

Proceeds from issuance of short-term notes and bills
payable

Repayment of short-term notes and bills payable

Proceeds from long-term borrowings

Repayment of long-term borrowings

Decrease in guanrantee deposits received

Repayment of principal portion of lease liabilities

Cash capital increase

Treasury shares transferred to employees

Acquisition of treasury stocks

Cash dividends paid

Net cash flows (used in) from financing
activities
Net (decrease) increase in cash and cash equivalents
Cash and cash equivalents at beginning of year

Cash and cash equivalents at end of year Year ended December 31
Notes
2025
2024
6(29)
($
8,680 ) ($
8,823 )
2,464
-
6(29)
(
8,488 ) (
4,790 )
(
1,555 )
17
(
16,259 ) (
13,596 )
6(30)
8,295,000
6,898,000
6(30)
(
8,315,000 ) (
7,016,000 )
6(30)
-
9,996
6(30)
- (
10,000 )
6(30)
176,400
900,000
6(30)
(
900,000 ) (
900,000 )
6(30)
25
-
6(30)
(
6,002 ) (
7,250 )
6(16)
-
719,154
6(16)
37,044
-
6(16)
(
2,847 )
-
6(18)
(
305,647 ) (
193,697 )
(
1,021,027 )
400,203
(
659,040 )
726,253
6(1)
1,105,899
379,646
6(1)
$
446,859 $
1,105,899

The accompanying notes are an integral part of these parent company only financial statements.

~14~

ALTEK CORPORATION NOTES TO THE PARENT COMPANY ONLY FINANCIAL STATEMENTS DECEMBER 31, 2025 AND 2024

(Expressed in thousands of New Taiwan dollars, except as otherwise indicated)

1. HISTORY AND ORGANISATION

Altek Corporation (the “Company”) was incorporated as a company limited by shares under the provisions of the Company Law of the Republic of China (R.O.C.). The Company is primarily engaged in the research, development, production, manufacturing and sale of AI imaging solutions and related application products such as medical products, and related export and import trade.

The Company was listed in the Taiwan Stock Exchange on December 24, 2002, as approved by the TaiTz (91) Letter No. 024976 of the former Securities and Futures Commission, Ministry of Finance, R.O.C., dated September 27, 2002.

THE DATE OF AUTHORISATION FOR ISSUANCE OF THE FINANCIAL STATEMENTS AND

PROCEDURES FOR AUTHORISATION

The parent company only financial statements were authorized for issuance by the Board of Directors on March 11, 2026.

3. APPLICATION OF NEW STANDARDS, AMENDMENTS AND INTERPRETATIONS

(1) Effect of the adoption of new issuances of or amendments to International Financial Reporting Standards (“IFRS[®] ”) Accounting Standards that came into effect as endorsed by the Financial Supervisory Commission (“FSC”)

New standards, interpretations and amendments endorsed by the FSC and became effective from 2025 are as follows:

New Standards,Interpretations and Amendments	Effective date by International Accounting Standards Board
Amendments to IAS 21, ‘Lack of exchangeability’	January 1, 2025

The above standards and interpretations have no significant impact to the Company’s financial condition and financial performance based on the Company’s assessment.

~15~

(2) Effect of new issuances of or amendments to IFRS Accounting Standards as endorsed by the FSC but

not yet adopted by the Company

New standards, interpretations and amendments endorsed by the FSC effective from 2026 are as follows:

==> picture [484 x 49] intentionally omitted <==

----- Start of picture text -----

Effective date by
International Accounting
New Standards, Interpretations and Amendments Standards Board
----- End of picture text -----

New Standards,Interpretations and Amendments	Standards Board
Amendments to IFRS 9 and IFRS 7, ‘Amendments to the classification	January 1, 2026
and measurement of financial instruments’
Amendments to IFRS 9 and IFRS 7, ‘Contracts referencing nature-	January 1, 2026
dependent electricity’
IFRS 17, ‘Insurance contracts’	January 1, 2023
Amendments to IFRS 17, ‘Insurance contracts’	January 1, 2023
Amendment to IFRS 17, ‘Initial application of IFRS 17 and IFRS 9 –	January 1, 2023
comparative information’
Annual Improvements to IFRS Accounting Standards—Volume 11	January 1, 2026

The above standards and interpretations have no significant impact to the Company’s financial condition and financial performance based on the Company’s assessment.

(3) IFRS Accounting Standards issued by IASB but not yet endorsed by the FSC

New standards, interpretations and amendments issued by IASB but not yet included in the IFRS Accounting Standards as endorsed by the FSC are as follows:

Accounting Standards as endorsed by the FSC are as follows:
New Standards,Interpretations and Amendments	Effective date by International Accounting Standards Board
Amendments to IFRS 10 and IAS 28, ‘Sale or contribution of assets between an investor and its associate or joint venture’ IFRS 18, ‘Presentation and disclosure in financial statements’ IFRS 19, ‘Subsidiaries without public accountability: disclosures’ 2027Amendments to IAS 21, ‘Translation to a HyperinflationaryPresentation Currency’	To be determined by International Accounting Standards Board January 1, 2027(Note) January 1, 2027 January 1, 2027

Note ： The FSC has announced in a press release on September 25, 2025 that public companies will apply IFRS 18 starting from the fiscal year 2028. Additionally, entities can choose to adopt IFRS 18 earlier based on their requirements after the FSC endorses IFRS 18.

~16~

Except for the following, the above standards and interpretations have no significant impact to the Company’s financial condition and financial performance based on the Company’s assessment. IFRS 18, ‘Presentation and disclosure in financial statements’

IFRS 18, ‘Presentation and disclosure in financial statements’ replaces IAS 1. The standard introduces a defined structure of the statement of comprehensive income, disclosure requirements related to management-defined performance measures, and enhanced principles on aggregation and disaggregation which apply to the primary financial statements and notes.

4. SUMMARY OF MATERIAL ACCOUNTING POLICIES

The principal accounting policies applied in the preparation of these accompanying parent company only financial statements are set out below. These policies have been consistently applied to all the periods presented, unless otherwise stated.

(1) Compliance statement

The parent company only financial statements have been prepared in accordance with the Regulations Governing the Preparation of Financial Reports by Securities Issuers.

(2) Basis of preparation
A. Except for the following items, the parent company only financial statements have been prepared under the historical cost convention:
- (a) Financial assets and financial liabilities (including derivative instruments) at fair value through profit or loss.
- (b) Financial assets at fair value through other comprehensive income.
- (c) Defined benefit liabilities recognised based on the net amount of pension fund assets less present value of defined benefit obligation.
B. The preparation of financial statements in conformity with International Financial Reporting Standards, International Accounting Standards, IFRIC Interpretations, and SIC Interpretations that came into effect as endorsed by the FSC (collectively referred herein as the “IFRSs”) requires the use of certain critical accounting estimates. It also requires management to exercise its judgement in the process of applying the Company’s accounting policies. The areas involving a higher degree of judgement or complexity, or areas where assumptions and estimates are significant to the parent company only financial statements are disclosed in Note 5.

(3) Foreign currency translation

Items included in the financial statements of the Company’s entities are measured using the currency of the primary economic environment in which the entity operates (the “functional currency”). The parent company only financial statements are presented in New Taiwan Dollar, which is the Company’s functional currency.

~17~

A. Foreign currency transactions and balances
(a) Foreign currency transactions are translated into the functional currency using the exchange rates prevailing at the dates of the transactions or valuation where items are remeasured. Foreign exchange gains and losses resulting from the settlement of such transactions are recognised in profit or loss in the period in which they arise.
(b) Monetary assets and liabilities denominated in foreign currencies at the period end are retranslated at the exchange rates prevailing at the balance sheet date. Exchange differences arising upon re-translation at the balance sheet date are recognised in profit or loss.
(c) Non-monetary assets and liabilities denominated in foreign currencies held at fair value through profit or loss are re-translated at the exchange rates prevailing at the balance sheet date; their translation differences are recognised in profit or loss. Non-monetary assets and liabilities denominated in foreign currencies held at fair value through other comprehensive income are re-translated at the exchange rates prevailing at the balance sheet date; their translation differences are recognised in other comprehensive income. However, nonmonetary assets and liabilities denominated in foreign currencies that are not measured at fair value are translated using the historical exchange rates at the dates of the initial transactions.
(d) All foreign exchange gains and losses are presented in the statement of comprehensive income within “other gains and losses”.
B. Translation of foreign operations
(a) The operating results and financial position of all the subsidiaries, associates and joint arrangements that have a functional currency different from the presentation currency are translated into the presentation currency as follows:
- i. Assets and liabilities for each balance sheet presented are translated at the closing exchange rate at the date of that balance sheet;
- ii. Income and expenses for each statement of comprehensive income are translated at average exchange rates of that period; and
- iii. All resulting exchange differences are recognised in other comprehensive income.
(b) When the foreign operation partially disposed of or sold is an associate or joint arrangement, exchange differences that were recorded in other comprehensive income are proportionately reclassified to profit or loss as part of the gain or loss on sale. In addition, even when the Company retains partial interest in the former foreign associate or joint arrangement after losing significant influence over the former foreign associate, or losing joint control of the former joint arrangement, such transactions should be accounted for as disposal of all interest in these foreign operations.

~18~

(c) When the foreign operation partially disposed of or sold is a subsidiary, cumulative exchange differences that were recorded in other comprehensive income are proportionately transferred to the non-controlling interest in this foreign operation. In addition, even when the Company retains partial interest in the former foreign subsidiary after losing control of the former foreign subsidiary, such transactions should be accounted for as disposal of all interest in the foreign operation.
(d) Goodwill and fair value adjustments arising on the acquisition of a foreign entity are treated as assets and liabilities of the foreign entity and translated at the closing exchange rates at the balance sheet date.

(4) Classification of current and non-current items

A. Assets that meet one of the following criteria are classified as current assets; otherwise they are classified as non-current assets:
(a) Assets arising from operating activities that are expected to be realised, or are intended to be sold or consumed within the normal operating cycle;
(b) Assets held mainly for trading purposes;
(c) Assets that are expected to be realised within twelve months after the reporting period;
(d) Cash and cash equivalents, excluding restricted cash and cash equivalents and those that are to be exchanged or used to settle liabilities for at least twelve months after the reporting period.
B. Liabilities that meet one of the following criteria are classified as current liabilities; otherwise they are classified as non-current liabilities:
(a) Liabilities that are expected to be settled within the normal operating cycle;
(b) Liabilities arising mainly from trading activities;
(c) Liabilities that are to be settled within twelve months after the reporting period;
(d) It does not have the right at the end of the reporting period to defer settlement of the liability at least twelve months after the reporting period.

(5) Cash equivalents

Cash equivalents refer to short-term, highly liquid investments that are readily convertible to known amounts of cash and which are subject to an insignificant risk of changes in value. Time deposits that meet the definition above and are held for the purpose of meeting short-term cash commitments in operations are classified as cash equivalents.

(6) Financial assets at fair value through profit or loss

A. Financial assets at fair value through profit or loss are financial assets that are not measured at amortised cost or fair value through other comprehensive income.
B. On a regular way purchase or sale basis, financial assets at fair value through profit or loss are recognised and derecognised using settlement date accounting.
C. At initial recognition, the Company measures the financial assets at fair value and recognises the transaction costs in profit or loss. The Company subsequently measures the financial assets at fair value, and recognises the gain or loss in profit or loss.

~19~

D. The Company recognises the dividend income when the right to receive payment is established, future economic benefits associated with the dividend will flow to the Company and the amount of the dividend can be measured reliably.
(7) Financial assets at fair value through other comprehensive income
A. Financial assets at fair value through other comprehensive income comprise equity securities which are not held for trading, and for which the Company has made an irrevocable election at initial recognition to recognise changes in fair value in other comprehensive income.
B. On a regular way purchase or sale basis, financial assets at fair value through other comprehensive income are recognised and derecognised using settlement date accounting.
C. At initial recognition, the Company measures the financial assets at fair value plus transaction costs. The Company subsequently measures the financial assets at fair value: The changes in fair value of equity investments that were recognised in other comprehensive income are reclassified to retained earnings and are not reclassified to profit or loss following the derecognition of the investment. Dividends are recognised as revenue when the right to receive payment is established, future economic benefits associated with the dividend will flow to the Company and the amount of the dividend can be measured reliably.
(8) Accounts receivable
A. Accounts receivable entitle the Company a legal right to receive consideration in exchange for transferred goods or rendered services.
B. The short-term accounts receivable without bearing interest are subsequently measured at initial invoice amount as the effect of discounting is immaterial.
(9) Impairment of financial assets
For financial assets at amortised cost at each reporting date, the Company recognises the impairment provision for 12 months expected credit losses if there has not been a significant increase in credit risk since initial recognition or recognises the impairment provision fot the lifetime expected credit losses (ECLs) if such credit erisk has increased since initial recognition after taking into consideration all reasonable and verifiable information that includes forecasts. On the other hand, for accounts receivable that does not contain a significant financing component, the Company recognises the impairment provision for lifetime ECLs.

(10) Derecognition of financial assets

The Company derecognises a financial asset when the contractual rights to receive the cash flows from the financial asset expire.

The Company derecognises a financial asset when one of the following conditions is met:

A. The contractual rights to receive the cash flows from the financial asset expire.
B. The contractual rights to receive cash flows of the financial asset have been transferred and the Company has transferred substantially all risks and rewards of ownership of the financial asset.
C. The contractual rights to receive cash flows of the financial asset have been transferred; however, the Company has not retained control of the financial asset.

~20~

－
(11) Leasing arrangements (lessor) operating leases

Lease income from an operating lease (net of any incentives given to the lessee) is recognised in profit or loss on a straight-line basis over the lease term.

(12) Inventories
Inventories are stated at the lower of cost and net realisable value. Cost is determined using the weighted-average method. The cost of finished goods and work in progress comprises raw materials, direct labour, other direct costs and related production overheads (allocated based on normal operating capacity). It excludes borrowing costs. The item by item approach is used in applying the lower of cost and net realisable value. Net realisable value is the estimated selling price in the ordinary course of business, less the estimated cost of completion and the estimated costs necessary to make the sale.

(13) Investments accounted for using equity method / associates

A. Subsidiaries are all entities controlled by the Company. The Company controls an entity when the Company is exposed, or has rights, to variable returns from its involvement with the entity and has ability to affect those returns through its power over the entity.
B. Unrealised profit (loss) that occurred from the transactions between the Company and subsidiaries have been offset. The accounting policies of the subsidiaries have been adjusted where necessary to ensure consistency with the policies adopted by the Company.
C. The Company’s share of its subsidiaries’ post-acquisition profits or losses is recognised in profit or loss, and its share of post-acquisition movements in other comprehensive income is recognised in other comprehensive income. When the Company’s share of losses in a subsidiary equals or exceeds its interest in the subsidiary, the Company continues to recognise its share in the subsidiary’s loss proportionately.
D. Changes in a parent’s ownership interest in a subsidiary that do not result in the parent losing control of the subsidiary (transactions with non-controlling interests) are accounted for as equity transactions, i.e. transactions with owners in their capacity as owners. Any difference between the amount by which the non-controlling interests are adjusted and the fair value of the consideration paid or received is recognised directly in equity.
E. Pursuant to the “Regulations Governing the Preparation of Financial Reports by Securities Issuers,” profit (loss) of the current period and other comprehensive income in the nonconsolidated financial statements shall be equal to the amount attributable to owners of the parent in the financial statements prepared with basis for consolidation. Owners’ equity in the non-consolidated financial statements shall be equal to equity attributable to owners of the parent in the consolidated financial statements.

(14) Property, plant and equipment

A. Property, plant and equipment are initially recorded at cost. Borrowing costs incurred during the construction period are capitalised.

~21~

B. Subsequent costs are included in the asset’s carrying amount or recognised as a separate asset, as appropriate, only when it is probable that future economic benefits associated with the item will flow to the Company and the cost of the item can be measured reliably. The carrying amount of the replaced part is derecognised. All other repairs and maintenance are charged to profit or loss during the financial period in which they are incurred.
C. Land is not depreciated. Other property, plant and equipment apply cost model and are depreciated using the straight-line method to allocate their cost over their estimated useful lives. Each part of an item of property, plant, and equipment with a cost that is significant in relation to the total cost of the item must be depreciated separately.
D. The assets’ residual values, useful lives and depreciation methods are reviewed, and adjusted if appropriate, at each financial year-end. If expectations for the assets’ residual values and useful lives differ from previous estimates or the patterns of consumption of the assets’ future economic benefits embodied in the assets have changed significantly, any change is accounted for as a change in estimate under IAS 8, ‘Accounting Policies, Changes in Accounting Estimates and Errors’, from the date of the change. The estimated useful lives of property, plant and equipment are as follows:

==> picture [404 x 40] intentionally omitted <==

(15) Leasing arrangements (lessee) － right-of-use assets/ lease liabilities

A. Leases are recognised as a right-of-use asset and a corresponding lease liability at the date at which the leased asset is available for use by the Company. For short-term leases or leases of low-value assets, lease payments are recognised as an expense on a straight-line basis over the lease term.
B. Lease liabilities include the net present value of the remaining lease payments at the commencement date, discounted using the incremental borrowing interest rate. The Company subsequently measures the lease liability at amortised cost using the interest method and recognises interest expense over the lease term. The lease liability is remeasured and the amount of remeasurement is recognised as an adjustment to the right-of-use asset when there are changes in the lease term or lease payments and such changes do not arise from contract modifications.
C. At the commencement date, the right-of-use asset is stated at cost comprising the following: (a) The amount of the initial measurement of lease liability; and (b) Any initial direct costs incurred by the lessee.
The right-of-use asset is measured subsequently using the cost model and is depreciated from the commencement date to the earlier of the end of the asset’s useful life or the end of the lease term. When the lease liability is remeasured, the amount of remeasurement is recognised as an adjustment to the right-of-use asset.

~22~

(16) Investment property

An investment property is stated initially at its cost and measured subsequently using the cost model. Except for land, investment property is depreciated on a straight-line basis over its estimated useful life of 10 ~ 35 years.

(17) Intangible assets

Computer software are stated at cost and amortised on a straight-line basis over its estimated useful lives of 1 ~ 5 years.

(18) Impairment of non-financial assets

The Company assesses at each balance sheet date the recoverable amounts of those assets where there is an indication that they are impaired. An impairment loss is recognised for the amount by which the asset’s carrying amount exceeds its recoverable amount. The recoverable amount is the higher of an asset’s fair value less costs to sell or value in use. Except for goodwill, when the circumstances or reasons for recognising impairment loss for an asset in prior years no longer exist or diminish, the impairment loss is reversed. The increased carrying amount due to reversal should not be more than what the depreciated or amortised historical cost would have been if the impairment had not been recognised.

(19) Borrowings

Borrowings comprise long-term and short-term bank borrowings. Borrowings are recognised initially at fair value, net of transaction costs incurred.

(20) Accounts payable

A. Accounts payable are liabilities for purchases of raw materials, goods or services.
B. The Company initially measures accounts payable at fair value and subsequently amortises the interest expense in profit or loss over the period of circulation using the effective interest method.

(21) Provisions

Provisions (warranties) are recognised when the Company has a present legal or constructive obligation as a result of past events, and it is probable that an outflow of economic resources will be required to settle the obligation and the amount of the obligation can be reliably estimated. Provisions are measured at the present value of the expenditures expected to be required to settle the obligation on the balance sheet date.

(22) Employee benefits

A. Short-term employee benefits

Short-term employee benefits are measured at the undiscounted amount of the benefits expected to be paid in respect of service rendered by employees in a period and should be recognised as expense in that period when the employees render service.

~23~

B. Pensions

(a) Defined contribution plans

For defined contribution plans, the contributions are recognised as pension expense when they are due on an accrual basis. Prepaid contributions are recognised as an asset to the extent of a cash refund or a reduction in the future payments.

(b) Defined benefit plans

  - i. Net obligation under a defined benefit plan is defined as the present value of an amount of pension benefits that employees will receive on retirement for their services with the Company in current period or prior periods. The liability recognised in the balance sheet in respect of defined benefit pension plans is the present value of the defined benefit obligation at the balance sheet date less the fair value of plan assets. The net defined benefit obligation is calculated annually by independent actuaries using the projected unit credit method. The rate used to discount is determined by using interest rates of high-quality corporate bonds that are denominated in the currency in which the benefits will be paid, and that have terms to maturity approximating to the terms of the related pension liability; when there is no deep market in high-quality corporate bonds, the Company uses interest rates of government bonds (at the balance sheet date) instead.

  - ii. Remeasurements arising on defined benefit plans are recognised in other comprehensive income in the period in which they arise and are recorded as retained earnings.

  - iii. Past service costs are recognised immediately in profit or loss.

C. Termination benefits
Termination benefits are employee benefits provided in exchange for the termination of employment as a result from either the Company’s decision to terminate an employee’s employment before the normal retirement date, or an employee’s decision to accept an offer of redundancy benefits in exchange for the termination of employment. The Company recognises expense as it can no longer withdraw an offer of termination benefits or it recognises relating restructuring costs, whichever is earlier. Benefits that are expected to be due more than 12 months after balance sheet date shall be discounted to their present value.
D. Employees’ compensation and directors’ remuneration
Employees’ compensation and directors’ remuneration are recognised as expense and liability, provided that such recognition is required under legal or constructive obligation and those amounts can be reliably estimated. Any difference between the resolved amounts and the subsequently actual distributed amounts is accounted for as changes in estimates. If employee compensation is paid by shares, the Company calculates the number of shares based on the closing price at the previous day of the board meeting resolution.

~24~

- (23) Employee share based payment

A. For the equity-settled share-based payment arrangements, the employee services received are measured at the fair value of the equity instruments granted at the grant date, and are recognised as compensation cost over the vesting period, with a corresponding adjustment to equity. The fair value of the equity instruments granted shall reflect the impact of market vesting conditions and non-vesting conditions. Compensation cost is subject to adjustment based on the service conditions that are expected to be satisfied and the estimates of the number of equity instruments that are expected to vest under the non-market vesting conditions at each balance sheet date. Ultimately, the amount of compensation cost recognised is based on the number of equity instruments that eventually vest.
B. Restricted stocks:
(a) Restricted stocks issued to employees are measured at the fair value of the equity instruments granted at the grant date, and are recognised as compensation cost over the vesting period.
(b) For restricted stocks where those stocks do not restrict distribution of dividends to employees and employees are not required to return the dividends received if they resign during the vesting period, the Company recognises the fair value of the dividends received by the employees who are expected to resign during the vesting period as compensation cost at the date of dividends declared.
(c) Employees do not need to pay a price to obtain new shares with restricted employee rights. If the employee leaves the Company within the vesting period, the Company will take back the stock from the employee free of charge. On the grant date, the Company estimated and recognized compensation costs and liabilities based on the issuance terms and conditions.

(24) Income tax

A. The tax expense for the period comprises current and deferred tax. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or items recognised directly in equity, in which cases the tax is recognised in other comprehensive income or equity.
B. The current income tax expense is calculated on the basis of the tax laws enacted or substantively enacted at the balance sheet date in the countries where the Company and its subsidiaries operate and generate taxable income. Management periodically evaluates positions taken in tax returns with respect to situations in accordance with applicable tax regulations. It establishes provisions where appropriate based on the amounts expected to be paid to the tax authorities. An additional tax is levied on the unappropriated retained earnings and is recorded as income tax expense in the year the stockholders resolve to retain the earnings.

~25~

C. Deferred tax is recognised, using the balance sheet liability method, on temporary differences arising between the tax bases of assets and liabilities and their carrying amounts in the consolidated balance sheet. However, the deferred tax is not accounted for if it arises from initial recognition of goodwill or of an asset or liability in a transaction other than a business combination that at the time of the transaction affects neither accounting nor taxable profit or loss. Deferred tax is provided on temporary differences arising on investments in subsidiaries and associates, except where the timing of the reversal of the temporary difference is controlled by the Company and it is probable that the temporary difference will not reverse in the foreseeable future. Deferred tax is determined using tax rates (and laws) that have been enacted or substantially enacted by the balance sheet date and are expected to apply when the related deferred tax asset is realised or the deferred tax liability is settled.
D. Deferred tax assets are recognised only to the extent that it is probable that future taxable profit will be available against which the temporary differences can be utilised. At each balance sheet date, unrecognised and recognised deferred tax assets are reassessed.
E. Current income tax assets and liabilities are offset and the net amount reported in the balance sheet when there is a legally enforceable right to offset the recognised amounts and there is an intention to settle on a net basis or realise the asset and settle the liability simultaneously. Deferred tax assets and liabilities are offset on the balance sheet when the entity has the legally enforceable right to offset current tax assets against current tax liabilities and they are levied by the same taxation authority on either the same entity or different entities that intend to settle on a net basis or realise the asset and settle the liability simultaneously.
F. A deferred tax asset shall be recognised for the carryforward of unused tax credits resulting from acquisitions of equipment or technology, research and development expenditures and equity investments to the extent that it is possible that future taxable profit will be available against which the unused tax credits can be utilised.

(25) Share capital

A. Ordinary shares are classified as equity. Incremental costs directly attributable to the issue of new shares or stock options are shown in equity as a deduction, net of tax, from the proceeds.
B. Where the Company repurchases the Company’s equity share capital that has been issued, the consideration paid, including any directly attributable incremental costs (net of income taxes) is deducted from equity attributable to the Company’s equity holders. Where such shares are subsequently reissued, the difference between their carrying amount and any consideration received, net of any directly attributable incremental transaction costs and the related income tax effects, is included in equity attributable to the Company’s equity holders.

(26) Dividends

Dividends are recorded in the Company’s financial statements in the period in which they are resolved by the Company’s shareholders. Cash dividends are recorded as liabilities.

~26~

(27) Revenue recognition

A. Sales of goods
(a) The Company manufactures and sells AI image technology application products. Sales are recognised when control of the products has transferred, being when the products are delivered to the buyer, the buyer has full discretion over the channel and price to sell the products, and there is no unfulfilled obligation that could affect the wholesaler’s acceptance of the products. Delivery occurs when the products have been shipped to the specific location, the risks of obsolescence and loss have been transferred to the wholesaler, and either the wholesaler has accepted the products in accordance with the sales contract, or the Company has objective evidence that all criteria for acceptance have been satisfied.
(b) Revenue from these sales is recognised based on the price specified in the contract, net of the value-added tax, sales return, volume discounts, sales discounts and allowances.
(c) The Company’s obligation to provide a repair for faulty products under the standard warranty terms is recognised as a provision.
(d) A receivable is recognised when the goods are delivered as this is the point in time that the consideration is unconditional because only the passage of time is required before the payment is due.
B. Technical service revenue
The Company provides technical support services. Revenue from providing services is recognised in the accounting period in which the services are rendered. For fixed-price contracts, revenue is recognised based on the actual service provided to the end of the reporting period as a proportion of the total services to be provided. This is determined based on the number of delivered report relative to the total number of committed report.
Critical Accounting Judgements, Estimates and Key Sources of Assumption Uncertainty

The preparation of the parent company only financial statements requires management to make critical judgements in applying the Company’s accounting policies and make critical assumptions and estimates concerning future events. Assumptions and estimates may differ from the actual results and are continually evaluated and adjusted based on historical experience and other factors.

(1) Critical judgements in applying the Company’s accounting policies None.

~27~

(2) Critical accounting estimates and assumptions

Evaluation of inventories

As inventories are stated at the lower of cost and net realisable value, the Company and its subsidiaries (shown as Investments accounted for under the equity method) must determine the net realisable value of inventories on balance sheet date using judgements and estimates. Due to the rapid technology innovation, the Company evaluates the amounts of normal inventory consumption, obsolete inventories or inventories without market selling value on balance sheet date, and writes down the cost of inventories to the net realisable value. Therefore, there might be material changes to the evaluation.

As of December 31, 2025, the carrying amount of inventories was $50,197.

6. DETAILS OF SIGNIFICANT ACCOUNTS

(1) Cash and cash equivalents

to the evaluation. As of December 31, 2025, the carrying amount of inventories was $50,197. TAILS OF SIGNIFICANT ACCOUNTS Cash and cash equivalents
December 31, 2025 Cash on hand revolving funds 658 $ Checking accounts and demand deposits 367,626 Time deposits 78,575 Total 446,859 $	December 31, 2024
	754 $ 1,105,145 -
	1,105,899 $

A. The Company transacts with a variety of financial institutions all with high credit quality to disperse credit risk, so it expects that the probability of counterparty default is remote.
B. The Company has no cash and cash equivalents pledged to others.

(2) Financial assets at fair value through profit or loss

Financial assets at fair value through profit or loss
Items Non-current items: Financial assets mandatorily measured at fair value through profit or loss Unlisted stocks Valuation adjustment Total	December 31,2025 10,312 $ 61,882 72,194 $	December 31,2024
		10,312 $ 70,199
		80,511 $

A. Amounts recognised in profit or loss in relation to financial assets at fair value through profit or loss are listed below:

loss are listed below:
Equity instruments (	For the year ended December 31,2025 8,317) $ (	For the year ended December 31,2024
		9,278) $

B. The Company has no financial assets at fair value through profit or loss as at December 31, 2025 and 2024 pledged to others.

~28~

(3) Financial assets at fair value through other comprehensive income

Items		December	31,2025		December	31,2024
Non-current items:
Equity instruments
Unlisted stocks		$	100,000		$	100,000
Valuation adjustment	(		100,000)	(		100,000)
Total		$	-		$	-

A. The Company has elected to classify equity instruments that are considered to be strategic investments as financial assets at fair value through other comprehensive income. The fair value of such investments both amounted to $0 as at December 31, 2025 and 2024.
B. There were no amounts recognised in profit or loss and other comprehensive income in relation to the financial assets at fair value through other comprehensive income for the years ended December 31, 2025 and 2024.
C. The Company has no financial assets at fair value through profit or loss pledged to others as at December 31, 2025 and 2024.

(4) Accounts receivable

Accounts receivable (including related parties) Less: Allowance for uncollectible accounts	December31,2025 383,518 $ 76) ( 383,442 $	December31,2024 411,864 $ 78) ( 411,786 $

A. The ageing analysis of accounts receivable and notes receivable that were past due but not impaired is as follows:

is as follows:
Not past due Up to 30 days 31 to 90 days	337,638 $ 40,880 5,000 383,518 $ December31,2025	December31,2024
		351,142 $ 52,492 8,230
		411,864 $

The above ageing analysis was based on past due date.

B. As at December 31, 2025 and 2024, accounts receivable were all from contracts with customers. And as of January 1, 2024, the balance of accounts receivable from contracts with customers amounted to $877,407.
C. None of the Company’s accounts receivable were pledged to others as collateral.
D. As at December 31, 2025 and 2024, without taking into account any collateral held or other credit enhancements, the maximum exposure to credit risk in respect of the amount that best represents the Company’s accounts receivable was $383,442 and $411,786 , respectively.
E. Information relating to credit risk of accounts receivable is provided in Note 12(2).

~29~

(5) Inventories

(5)	Inventories
(6)	The cost of inventories recognised as expense for the period: Investments accounted for using equity method Cost Allowance for valuation loss Raw materials 11,344 $ 5,211) ($ Work in progress 38,987 4,872) ( Finished goods 13,051 3,102) ( Total 63,382 $ 13,185) ($ December 31,2025 Cost Allowance for valuation loss Raw materials 13,558 $ 4,854) ($ Work in progress 63,665 5,298) ( Finished goods 26,644 2,311) ( Total 103,867 $ 12,463) ($ December 31,2024 For the year ended December31,2025 Cost of goods sold and others 2,656,677 $ Loss in market value 722 Total 2,657,399 $ December 31, 2025 altek International Investment Co., Ltd. 8,932,841 $ Altek Japan Corporation 9,400 Altek International Holding (BVI) Co., Ltd. 1,388,392 Altek Investment Corporation 100,540 Altek Medical Pte. Ltd. 536,857 10,968,030 $	Book value 6,133 $ 34,115 9,949 50,197 $ Book value 8,704 $ 58,367 24,333 91,404 $ For the year ended December31,2024
		2,331,582 $ 884
		2,332,466 $
		December31,2024
		8,812,142 $ 9,790 1,427,003 100,583 962,619
		11,312,137 $

A. For information on the Company’s subsidiary, please refer to Note 4(3) in the consolidated financial statements for the year ended December 31, 2025.
B. The Company recognised gain on investment in associates amounting to $670,555 and $599,332 for the years ended December 31, 2025 and 2024, respectively.

~30~

(7) Property, plant and equipment

2025

At January 1 Cost Accumulated depreciation Opening net book amount Additions Disposals Reclassifications Depreciation charge Closing net book amount At December 31 Cost Accumulated depreciation	Land 248,826 $ - ( 248,826 $ 248,826 $ - - - - ( 248,826 $ 248,826 $ - ( 248,826 $	Buildings and structures Testequipment 1,053,176 $ 60,737 $ 432,794) 53,515) ( ( 620,382 $ 7,222 $ 620,382 $ 7,222 $ 1,492 288 - 2,464) ( 8,435 - 27,483) 2,903) ( ( 602,826 $ 2,143 $ 1,063,103 $ 54,582 $ 460,277) 52,439) ( ( 602,826 $ 2,143 $	Construction in progress and prepayment for Others equipment Total 57,523 $ 9,323 $ 1,429,585 $ 54,387) - 540,696) ( 3,136 $ 9,323 $ 888,889 $ 3,136 $ 9,323 $ 888,889 $ 695 4,284 6,759 - - 2,464) ( 152 8,587) ( - 2,050) - 32,436) ( 1,933 $ 5,020 $ 860,748 $ 58,370 $ 5,020 $ 1,429,901 $ 56,437) - 569,153) ( 1,933 $ 5,020 $ 860,748 $

~31~

2024

At January 1 Cost Accumulated depreciation Opening net book amount Additions Depreciation charge Closing net book amount At December 31 Cost Accumulated depreciation	Buildings and Land structures Testequipment Others 248,826 $ 1,052,510 $ 60,452 $ 57,129 $ - 405,881) ( 50,785) ( 52,173) ( 248,826 $ 646,629 $ 9,667 $ 4,956 $ 248,826 $ 646,629 $ 9,667 $ 4,956 $ - 666 1,100 394 - 26,913) ( 3,545) ( 2,214) ( 248,826 $ 620,382 $ 7,222 $ 3,136 $ 248,826 $ 1,053,176 $ 60,737 $ 57,523 $ - 432,794) ( 53,515) ( 54,387) ( 248,826 $ 620,382 $ 7,222 $ 3,136 $	Construction in progress and to be inspected equipment Total 792 $ 1,419,709 $ - 508,839) ( 792 $ 910,870 $ 792 $ 910,870 $ 8,531 10,691 - 32,672) ( 9,323 $ 888,889 $ 9,323 $ 1,429,585 $ - 540,696) ( 9,323 $ 888,889 $

A. For the years ended December 31, 2025 and 2024, there was no capitalisation of borrowing interests attributable to the property, plant and equipment.

B. Information about the property, plant and equipment that were pledged to others as collaterals is provided in Note 8.

~32~

`－` (8) Leasing arrangements lessee

A. The Company leases various assets including land, buildings and business vehicles. The term of the land lease contract is 20 years, the rest usually ranges from 2 to 3 years. Lease terms are negotiated on an individual basis and contain a wide range of different terms and conditions. The lease agreements do not impose covenants, but leased assets may not be used as security for borrowing purposes.
B. Short-term leases with a lease term of 12 months or less comprise buildings and equipment. Lowvalue assets comprise printers, etc.
C. The carrying amount of the depreciation charge are as follows:

Land Buildings Transportation equipment (Business vehicles) Land Buildings Transportation equipment (Business vehicles)	December 31, 2025 December31,2024 75,620 $ 78,854 $ - 1,731 2,337 - 77,957 $ 80,585 $ Carryingamount Depreciationcharge	December31,2024 amount
		78,854 $ 1,731 -
		80,585 $
	For the year ended December31,2025 3,140 $ 1,731 615 5,486 $	For the year ended December 31, 2024
		3,144 $ 3,460 -
		6,604 $

D. For the years ended December 31, 2025 and 2024, the additions to right-of-use assets were $2,858 and $0, respectively.
E. The information on profit and loss accounts relating to lease contracts is as follows:

Items affecting profit or loss Interest expense on lease liabilities Expense on short-term lease contracts Expense on leases of low-value assets Gain on sale and leaseback transactions	For the year ended December 31,2025 947 $ 3,594 243 2,756	For the year ended December 31,2024
		1,015 $ 2,018 342 -

F. For the years ended December 31, 2025 and 2024, the Company’s total cash outflow for leases were $9,839 and $9,610, respectively.

~33~

G. Extension and termination options

In determining the lease term, the Company takes into consideration all facts and circumstances that create an economic incentive to exercise an extension option. The assessment of lease period is reviewed if a significant event occurs which affects the assessment.

(9) Investment property

Investment property
At January 1 Cost Accumulated depreciation At January 1 Depreciation charge At December 31 At December 31 Cost Accumulated depreciation At January 1 Cost Accumulated depreciation At January 1 Depreciation charge At December 31 At December 31 Cost Accumulated depreciation	Land Buildings and structures Total 573,532 $ 245,411 $ 818,943 $ - 89,494) ( 89,494) ( 573,532 $ 155,917 $ 729,449 $ 573,532 $ 155,917 $ 729,449 $ - 6,810) ( 6,810) ( 573,532 $ 149,107 $ 722,639 $ 573,532 $ 245,411 $ 818,943 $ - 96,304) ( 96,304) ( 573,532 $ 149,107 $ 722,639 $ 2025 Land Buildingsand structures Total 573,532 $ 245,411 $ 818,943 $ - 82,684) ( 82,684) ( 573,532 $ 162,727 $ 736,259 $ 573,532 $ 162,727 $ 736,259 $ - 6,810) ( 6,810) ( 573,532 $ 155,917 $ 729,449 $ 573,532 $ 245,411 $ 818,943 $ - 89,494) ( 89,494) ( 573,532 $ 155,917 $ 729,449 $ 2024
	Land 573,532 $ - 573,532 $ 573,532 $ - 573,532 $ 573,532 $ - 573,532 $

Investment property

At January 1
Cost
Accumulated depreciation
At January 1
Depreciation charge
At December 31
At December 31
Cost
Accumulated depreciation
At January 1
Cost
Accumulated depreciation
At January 1
Depreciation charge
At December 31
At December 31
Cost
Accumulated depreciation

Land
Buildings and structures
Total
573,532
$ 245,411
$ 818,943
$ -
89,494)
(
89,494)
(
573,532
$ 155,917
$ 729,449
$ 573,532
$ 155,917
$ 729,449
$ -
6,810)
(
6,810)
(
573,532
$ 149,107
$ 722,639
$ 573,532
$ 245,411
$ 818,943
$ -
96,304)
(
96,304)
(
573,532
$ 149,107
$ 722,639
$ 2025
Land
Buildingsand structures
Total
573,532
$ 245,411
$ 818,943
$ -
82,684)
(
82,684)
(
573,532
$ 162,727
$ 736,259
$ 573,532
$ 162,727
$ 736,259
$ -
6,810)
(
6,810)
(
573,532
$ 155,917
$ 729,449
$ 573,532
$ 245,411
$ 818,943
$ -
89,494)
(
89,494)
(
573,532
$ 155,917
$ 729,449
$ 2024

Land
573,532
$ -

573,532
$ 573,532
$ -

573,532
$ 573,532
$ -

573,532
$

~34~

A. Rental income from investment property and direct operating expenses arising from investment property are shown below:

property are shown below:
Rental income from investment property Direct operating expenses arising from the investment property that generated rental income during the year	For the year ended December31,2025 27,655 $ 8,552 $	For the year ended December31,2024
		27,647 $
		8,723 $

B. The fair value of the investment property held by the Company as at December 31, 2025 and 2024 were both $1,051,328, which was valued by independent appraisers. Valuations were made using the comparative method and direct capitalization approach under income approach, which is categorised within Level 3 in fair value hierarchy.
C. There was no capitalisation of borrowing interests attributable to investment property.
D. Information about the investment property that was pledged to others as collaterals is provided in Note 8.

(10) Intangible assets

in Note 8. Intangible assets
A. Details of amortisation on intangible assets are as follows: 2025 At January 1 Cost 8,726 $ Accumulated amortisation 5,048) ( 3,678 $ At January 1 3,678 $ Additions 9,599 Amortisation charge 5,807) ( At December 31 7,470 $ At December 31 Cost 17,387 $ Accumulated amortisation 9,917) ( 7,470 $ For the year ended December 31,2025 Operating expense 5,807 $	2024
	9,246 $ 6,629) (
	2,617 $
	2,617 $ 4,949 3,888) (
	3,678 $
	8,726 $ 5,048) (
	3,678 $
	For the year ended December 31,2024 3,888 $

B. The Company has no intangible assets pledged to others.

~35~

(11) Short-term borrowings

Long-term borrowings
Type of borrowings
December 31,2025
Bank borrowings
Unsecured borrowings
1,850,000
$
Type of borrowings
December 31,2024
Bank borrowings
Unsecured borrowings
1,870,000
$
Type ofborrowings
Borrowing period
Bank secured
borrowings
July 11, 2025 to July 11, 2027.
Less: Current portion
Type ofborrowings
Borrowing period
Bank secured
borrowings
July 11, 2024 to July 11, 2026.
Less: Current portion

Interest rate range
Collateral
1.82%~1.89%
None
Interest rate range
Collateral
1.85%~1.99%
None
Interest
rate
range
Collateral
December 31, 2025
2.0%~2.1%
Note
176,400
$ -
176,400
$ Interest
rate
range
Collateral
December31,2024
2.0%~2.1%
Note
900,000
$ -
900,000
$

- (12) Long term borrowings

Note: For details of the collateral of long-term borrowings, please refer to Note 8.

The Company's medium- and long-term loan contract expired on June 9, 2025. Due to financial planning considerations, the Company has renewed the loan in advance on July 11, 2024.

The Company 's medium- and long-term loan contract expired on July 11, 2026. Due to financial planning considerations, the Company has repaid part of the borrowings in advance on January 3, 2025 and renewed the loan in advance on July 11, 2025.

~36~

(13) Pensions

A. (a) The Company has a defined benefit pension plan in accordance with the Labor Standards Act, covering all regular employees’ service years prior to the enforcement of the Labor Pension Act on July 1, 2005 and service years thereafter of employees who chose to continue to be subject to the pension mechanism under the Labor Standards Act. Under the defined benefit pension plan, two units are accrued for each year of service for the first 15 years and one unit for each additional year thereafter, subject to a maximum of 45 units. Pension benefits are based on the number of units accrued and the average monthly salaries and wages of the last 6 months prior to retirement. The Company contributes monthly an amount equal to 2% of the employees’ monthly salaries and wages to the retirement fund deposited with Bank of Taiwan, the trustee, under the name of the independent retirement fund committee. The labor pension reserve accrued by the Company has reached a sufficient amount to cover the labor pension obligations. With the approval of the competent authority, the Company is permitted to suspend the labor pension contributions from January 1, 2026 through December 31, 2026.
(b) The amounts recognised in the balance sheet are as follows:

	December	31,2025	December	31, 2024
Present value of defined benefit obligations	($	40,187)	($	40,143)
Fair value of plan assets		58,269		53,566
Net defined benefit asset	$	18,082	$	13,423

At January 1 Interest (expense) income Remeasurements: Return on plan assets (excluding amounts included in interest income or expense) Change in financial assumptions Experience adjustments Pension fund contribution Paid pension At December 31			2025
	Present value of defined benefit obligations		Fair value ofplan assets		Net defined benefit asset
	40,143) ($ 642) ( 40,785) ( - 810) ( 1,167 357 - 241 40,187) ($	(	53,566 $ 857 54,423 3,700 - - 3,700 387 241) 58,269 $	13,423 $ 215 13,638 3,700 810) ( 1,167 4,057 387 - 18,082 $

~37~

At January 1 Interest (expense) income Remeasurements: Return on plan assets (excluding amounts included in interest income or expense) Change in financial assumptions Experience adjustments Pension fund contribution Paid pension At December 31	Present value of defined benefit obligations 53,151) ($ 638) ( 53,789) ( - 1,243 3,893 5,136 - 8,510 ( 40,143) ($	Fair value ofplan assets Net defined benefit asset(liability) 49,856 $ 3,295) ($ 598 40) ( 50,454 3,335) ( 4,387 4,387 - 1,243 - 3,893 4,387 9,523 1,005 1,005 2,280) 6,230 53,566 $ 13,423 $ 2024

(d) The Bank of Taiwan was commissioned to manage the Fund of the Company’s and domestic subsidiaries’ defined benefit pension plan in accordance with the Fund’s annual investment and utilisation plan and the “Regulations for Revenues, Expenditures, Safeguard and Utilisation of the Labor Retirement Fund” (Article 6: The scope of utilisation for the Fund includes deposit in domestic or foreign financial institutions, investment in domestic or foreign listed, over-the-counter, or private placement equity securities, investment in domestic or foreign real estate securitization products, etc.). With regard to the utilisation of the Fund, its minimum earnings in the annual distributions on the final financial statements shall be no less than the earnings attainable from the amounts accrued from two-year time deposits with the interest rates offered by local banks. If the earnings is less than aforementioned rates, government shall make payment for the deficit after being authorized by the Regulator. The Company and domestic subsidiaries have no right to participate in managing and operating that fund and hence the Company and domestic subsidiaries are unable to disclose the classification of plan assets fair value in accordance with IAS 19 paragraph 142. The composition of fair value of plan assets as of December 31, 2025 and 2024 is given in the Annual Labor Retirement Fund Utilisation Report announced by the government.

~38~

(e) The principal actuarial assumptions used were as follows:

Discount rate Future salary increases	For the year ended December31,2025 1.30% 4.00%	For the year ended December31,2024
		1.60%
		4.00%

Assumptions regarding future mortality are set based on actuarial advice in accordance with published statistics and experience in Taiwan life insurance industry after 2025 and 2024. Because the main actuarial assumption changed, the present value of defined benefit obligation is affected. The analysis was as follows:

Discount rate Future salary increases Increase 0.25% Decrease 0.25% Increase 0.25% Decrease 0.25%

December 31, 2025

Effect on present value of defined benefit obligations ($ 676) $ 694 $ 586 ($ 575) December 31, 2024 Effect on present value of defined benefit obligations ($ 749) $ 770 $ 662 ($ 648)

The sensitivity analysis above is based on one assumption which changed while the other conditions remain unchanged. In practice, more than one assumption may change all at once. The method of analysing sensitivity and the method of calculating net pension liability in the balance sheet are the same.

The methods and types of assumptions used in preparing the sensitivity analysis did not change compared to the previous period.

(f) There are no expected contributions to the defined benefit pension plans of the Company for the year ending December 31, 2026.
(g) As of December 31, 2025, the weighted average duration of the retirement plan is 7 years. The analysis of timing of the future pension payment was as follows:

Within 1 year 2-5 years 5-10 years	5,112 $ 11,806 16,797
	33,715 $

~39~

B. Effective July 1, 2005, the Company has established a defined contribution pension plan (the “New Plan”) under the Labor Pension Act (the “Act”), covering all regular employees with R.O.C. nationality. Under the New Plan, the Company contributes monthly an amount based on 6% of the employees’ monthly salaries and wages to the employees’ individual pension accounts at the Bureau of Labor Insurance. The benefits accrued are paid monthly or in lump sum upon termination of employment. The pension costs under defined contribution pension plans of the Company for the years ended December 31, 2025 and 2024, were $15,743 and $16,120, respectively, under the above pension scheme.

(14) Share-based payment

A. For the years ended December 31, 2025 and 2024, the Company’s share-based payment arrangements were as follows:

arrangements were as follows:
Type of arrangement Grant date Treasury shares transferred to employees November 8, 2024 Cash capital increase reserved for employee subscription December 16, 2024 Plan for restricted shares to employees (2024-1) August 05, 2025	Quantity granted (shares in thousand)	Contract period	Vesting conditions
	2,090 2,700 1,495	- - 2 years	Immediately vested Immediately vested Note

Note ： The restricted shares were issued at no consideration to the Company and its domestic and foreign controlled or affiliated company’s existing employees whose service years have reached 1 year and 2 years and who achieved the performance condition as required by the Company. The vested ratio is 50% and 50%, respectively. If employees who are entitled to receive restricted shares do not meet the vesting conditions, the Company will retrieve at no consideration and retire those shares. The shares and dividends distributed to employees during the vesting period shall be given by the Company at no consideration. Employees are not required to return the shares and dividends if they resign during the vesting period.
B. Restricted shares to employees:

The information on restricted shares to employees is as follows (share in thousands):

Restricted stocks not vested at January 1 Options granted Restricted stocks not vested at December 31	2025 - 1,495 1,495	2024
		- -
		-

~40~

C. For information of fair value of the share-based payment transaction given by the Company is as follows:

Type of arrangement	Grant date	Share price (in NT dollar)	Exercise price (in NT dollar)	Expected price volatility	Expected option life	Expected dividends	Risk-free interest rate	Weighted average fair value per unit (in NT dollar)
Treasury shares transferred to employees Cash capital increase reserved for employee preemption Plan for restricted shares to employees (2024-1)	November 08, 2024 December 16, 2024 August 05, 2025	33.85 $ 29.15 45.35	18.24 $ 26.80 -	N/A N/A N/A	- - 2 years	N/A N/A N/A	N/A N/A N/A	33.85 $ 29.15 45.35

D. Expenses incurred on share-based payment transactions are shown below:

(15)	Provisions Equity-settled	For the year ended For the year ended December 31,2025 December 31,2024 10,657 $ 17,626 $

Provisions
At January 1, 2025 Additional provisions At December 31, 2025 Current	Warranty 49,482 $ 2,253 51,735 $ December31,2025 December 31, 2024 51,735 $ 49,482 $	Warranty
		49,482 $ 2,253
		51,735 $

The Company provides warranties on AI image-related application products sold. Provision for warranty is estimated based on historical warranty data of digital image technology application products.

(16) Share capital

As of December 31, 2025, the Company’s authorized capital was $5,000,000, consisting of 500,000

thousand shares of ordinary stock, and the paid-in capital was $3,072,420 with a par value of $10 (in NT dollars) per share.

A. Movements in the number of the Company’s ordinary shares outstanding are as follows (share in thousands):

in thousands):
At January 1 Cash capital increase Treasury shares transferred to employees Employee restricted shares Shares repurchases ( At December 31	2025 303,710 - 2,037 1,495 100) 307,142	2024
		276,710 27,000 - - -
		303,710

~41~

B. Treasury shares
(a) Reason for share reacquisition and the number of the Company’s treasury shares are as follows :

follows :
Name of company holding the shares	Reason for reacquisition To be reissued to employees Reason for reacquisition To be reissued to employees	Number of shares (share in thousands) 100 Number of shares (share in thousands) 2,090 December December	Carryingamount 2,847 $ 31, 2025
The Company Name of company holding the shares
			Carrying amount 31, 2024
The Company			38,101 $

(b) Pursuant to the R.O.C. Securities and Exchange Act, the number of shares bought back as treasury share should not exceed 10% of the number of the Company’s issued and outstanding shares and the amount bought back should not exceed the sum of retained earnings, paid-in capital in excess of par value and realised capital surplus.
(c) Pursuant to the R.O.C. Securities and Exchange Act, treasury shares should not be pledged as collateral and is not entitled to dividends before it is reissued.
(d) Pursuant to the R.O.C. Securities and Exchange Act, treasury shares should be reissued to the employees within five years from the reacquisition date and shares not reissued within the five-year period are to be retired.
(e) On November 8, 2024, the Company’s Board of Directors resolved to transfer treasury shares of 2,090 thousand shares to employees at the current transfer price of NT$18.24 (in dollars) per share in accordance with the regulations on repurchasing shares and transferring to employees (the actual number of treasury shares transferred to employees was 2,037 thousand shares).
(f) The first repurchase of treasury shares in 2020 would reach 5 years on March 18, 2025 and the number of treasury shares which were not transferred to employees was 53 thousand shares. On March 14, 2025, the Company’s Board of Directors resolved to set an effective date of capital reduction on March 19, 2025 and retire 53 thousand shares. The registration was completed.
(g) On April 8, 2025, the Company’s Board of Directors resolved to transfer treasury shares of 100 thousand shares to employees, with an average repurchase price of 28.47 per share, which has not been transferred to employees.

~42~

(17) Capital surplus

Pursuant to the R.O.C. Company Act, capital surplus arising from paid-in capital in excess of par value on issuance of common stocks and donations can be used to cover accumulated deficit or to issue new stocks or cash to shareholders in proportion to their share ownership, provided that the Company has no accumulated deficit. Further, the R.O.C. Securities and Exchange Act requires that the amount of capital surplus to be capitalised mentioned above should not exceed 10% of the paidin capital each year. Capital surplus should not be used to cover accumulated deficit unless the legal reserve is insufficient.

reserve is insufficient.
At January 1 Changes in ownership interests in subsidiaries Treasury shares transfer to employees Retirement of treasury shares Restricted shares to employees At December 31 At January 1 Cash capital increase Changes in ownership interests in subsidiaries Treasury shares transfer to employees At December 31	Share Employee stock Changes in ownership interests in Treasury shares premium options subsidiaries transaction 2,380,957 $ 32,625 $ 8,385 $ 120,936 $ - - 8,348) ( - - 31,798) ( - 31,706 412) ( 827) ( - 804 - - - - 2,380,545 $ - $ 37 $ 153,446 $ 2025 2024					Restricted stocks to employees	Total 2,542,903 $ 8,348) ( 92) ( 435) ( 52,848 2,586,876 $	Total
						- $ - - - 52,848
		$				52,848 $		2,586,876 $

	Share premium 1,925,458 $ 455,499 - - 2,380,957 $		Employee stockoptions - $ - - 32,625 32,625 $	Changes in ownership interests in subsidiaries - $ - 8,385 - 8,385 $	Treasury shares transcations 120,936 $ - - - 120,936 $			Total
							2,046,394 $ 455,499 8,385 32,625
							2,542,903 $

(18) Retained earnings

A. According to the Company’s Articles of Incorporation, the annual earnings, if any, shall first be used to pay all taxes and offset prior years’ operating losses and then 10% of the remaining amount shall be set aside as legal reserve. Special reserve shall be set aside in accordance with the rules. The remaining amount plus the unappropriated earnings of prior years were distributed in new shares, which were proposed by the Board of Directors and resolved at the shareholders’ meeting.

~43~

All or some of the dividends and bonus could, by a resolution adopted by a majority vote at a meeting of Board of Directors attended by two-thirds of the total number of directors, be distributed in the form of cash and reported at the shareholders’ meeting.

B. The amount of dividends appropriated is based on the Company’s current year’s net income and prior years’ retained earnings, taking into account the Company’s financial structure and future operating plans. The distribution ratio of cash dividends to stock dividends is based on the Company’s funding status, diluted earnings per share and other factors. According to the dividend policy adopted by the Board of Directors, cash dividends shall account for at least 20% of the total dividends distributed.
C. Except for covering accumulated deficit or issuing new stocks or cash to shareholders in proportion to their share ownership, the legal reserve shall not be used for any other purpose. The use of legal reserve for the issuance of stocks or cash to shareholders in proportion to their share ownership is permitted, provided that the balance of the reserve exceeds 25% of the Company’s paid-in capital.
D. (a) In accordance with the regulations, the Company shall set aside special reserve from the debit balance on other equity items at the balance sheet date before distributing earnings. When debit balance on other equity items is reversed subsequently, the reversed amount could be included in the distributable earnings.
(b) The amounts previously set aside by the Company as special reserve on initial application of IFRSs in accordance with Order No. Financial-Supervisory-Securities-Corporate1090150022, dated March 31, 2021, shall be reversed proportionately when the relevant assets are used, disposed of or reclassified subsequently. Such amounts are reversed upon disposal or reclassified if the assets are investment property of land, and reversed over the use period if the assets are investment property other than land.
E. The appropriation of 2024 and 2023 earnings had been resolved at the stockholders’ meeting on June 19, 2025 and June 13, 2024, respectively. Details are summarized below:

Dividends per share Amount (inNTdollars) Legal reserve 32,563 $ Special reserve 441,690) ( Cash dividends 305,647 1.0 $ 2024	2023	2023
	Dividends per share Amount (inNTdollars) 27,926 $ 108,904 193,697 0.7 $
		0.7 $

The appropriation of 2024 and 2023 earnings were the same as that approved by the Board of Directors on May 8, 2025 and March 11, 2024, respectively.

~44~

F. The appropriation of 2025 earnings had been resolved at the shareholders’ meeting on March 11, 2026. Details are summarised below:

2026. Details are summarised below:
			2025
			Dividends per share
		Amount		(in NTdollars)
Legal reserve	$	28,055
Special reserve		131,032
Cash dividends		307,142	$	1.0

The aforementioned 2025 earnings distribution proposal, except for the cash dividends that were approved by the Board of Directors on March 11, 2026, is still subject to approval by the shareholders’ meeting.

(19) Other equity items

shareholders’ meeting. Other equity items
Foreign currency Unrealised gains Unearned translation (losses) onvaluation compensation Total At January 1 852 $ 182,626) ($ - $ 181,774) ($ Valuation adjustment - 19,248) ( - 19,248) ( Valuation adjustment to retained earnings -Subsidiaries - 89,432 - 89,432 Currency translation differences-Subsidiaries 202,068) ( - - 202,068) ( Retirement of restricted shares to employees - - 67,798) ( 67,798) ( Share-based payment transactions-Restricted Stocks to Employees - - 21,187 21,187 At December 31 201,216) ($ 112,442) ($ 46,611) ($ 360,269) ($ 2025	2025
			Total

					2024
		Foreign currency			Unrealised gains
		translation		(losses) onvaluation			Total
At January 1	($	445,272)	($		179,044)	($		624,316)
Valuation adjustment		-	(		3,582)	(		3,582)
Currency translation
differences-Subsidiaries		446,124			-			446,124
At December 31	$	852	($		182,626)	($		181,774)

~45~

(20) Operating revenue

Operating revenue
	For the year ended	For the year ended
	December 31,2025	December 31,2024
Revenue from contracts with customers	3,007,608 $	2,764,952 $

A. Disaggregation of revenue from contracts with customers

The Company derives revenue from the transfer of goods and services over time and at a point in time in the following major geographical regions:

==> picture [477 x 287] intentionally omitted <==

----- Start of picture text -----

For the year ended
December 31, 2025 Asia Europe America Africa Taiwan Total
Revenue from external
customer contracts $ 2,338,816 $ 50,610 $ 522,231 $ 12,736 $ 83,215 $ 3,007,608
Timing of revenue
recognition
At a point in time $ 2,320,788 $ 30,804 $ 416,895 $ 12,736 $ 4,290 $ 2,785,513
Over time 18,028 19,806 105,336 - 78,925 222,095
Total $ 2,338,816 $ 50,610 $ 522,231 $ 12,736 $ 83,215 $ 3,007,608
For the year ended
December 31, 2024 Asia Europe America Taiwan Total
Revenue from
external customer
contracts $ 1,914,867 $ 36,903 $ 753,765 $ 59,417 $ 2,764,952
Timing of revenue
recognition
At a point in time $ 1,871,793 $ 34,785 $ 703,167 $ 962 $ 2,610,707
Over time 43,074 2,118 50,598 58,455 154,245
Total $ 1,914,867 $ 36,903 $ 753,765 $ 59,417 $ 2,764,952
----- End of picture text -----

B. Contract liabilities

The Group has recognised the following revenue-related contract liabilities:

Contract liabilities	December31,2025 64,572 $	December31,2024 138,102 $	January1,2024
			138,364 $

C. Revenue recognised from performance obligations satisfied in previous periods

Year ended December Year ended December 31, 2025 31, 2024 Revenue recognised that was included in the contract liability balance at the beginning of the period $ 94,797 $ 56,421

~46~

(21) Interest income

Interest income
Other income Other income and expenses Finance costs Expenses by nature For the year ended For the year ended December31,2025 December 31, 2024 Interest income from bank deposits 2,660 $ 3,007 $ Other interest income 13 1 2,673 $ 3,008 $ For the year ended For the year ended December 31, 2025 December 31, 2024 Rent income 22,831 $ 23,181 $ Dividend income 3,814 3,052 Other income - others 6,096 3,284 32,741 $ 29,517 $ For the year ended For the year ended December31,2025 December31,2024 Net losses on financial assets at fair value through profit or loss 8,317) ($ 9,278) ($ Net currency exchange gains 8,595 11,325 Gain arising form lease modification 2,756 - Other expenses - 1,805) ( 3,034 $ 242 $ For the year ended For the year ended December31,2025 December31,2024 Interest expense : Bank loan 40,163 $ 49,214 $ Lease liabilities 947 1,015 Other - 4 41,110 $ 50,233 $ For the year ended For the year ended December31,2025 December31,2024 Employee benefit expenses 460,047 $ 493,180 $ Depreciation charges on property, plant and equipment 32,436 32,672 Depreciation charges on right-of-use assets 5,486 6,604 Depreciation charges on investment property 6,810 6,810 Amortisation charges on intangible assets 5,807 3,888		For the year ended December 31, 2024
		3,007 $ 1
		3,008 $
		For the year ended December 31, 2024
		23,181 $ 3,052 3,284 29,517 $

		49,214 $ 1,015 4
		50,233 $
		For the year ended December31,2024
		493,180 $ 32,672 6,604 6,810 3,888

(22) Other income

(23) Other income and expenses

(24) Finance costs

(25) Expenses by nature

~47~

(26) Employee benefit expense

Employee benefit expense
		For the year ended		For the year ended
	December 31, 2025		December 31, 2024
Wages and salaries	$	398,763	$	423,643
Share-based payment compensation costs		10,657		17,626
Labour and health insurance fees		27,003		27,345
Pension costs		15,528		16,160
Other personnel expenses		8,096		8,406
	$	460,047	$	493,180

A. According to the Articles of Incorporation of the Company, employees’ compensation and directors’ remuneration shall be calculated based on current year’s earnings, which should first be used to cover accumulated deficit, if any, 5% to 20% for employees’ compensation, with no less than 15% of this amount allocated to rank-and-file employees, and no more than 5% for directors’ remuneration. Employees’ compensation can be distributed in the form of shares or in cash. Employees of subsidiaries that the Company holds more than 50% shareholding are entitled to receive aforementioned shares or cash.
Abovementioned distributable profit of the current period refers to the pre-tax profit before deduction of employees’ compensation and directors’ remuneration. A company may, by a resolution adopted by a majority vote at a meeting of Board of Directors attended by two-thirds of the total number of directors, distribute employees’ compensation and directors’ remuneration and report such distribution to the shareholders’ meeting.
B. For the years ended December 31, 2025 and 2024, employees’ compensation were accrued at $44,767 and $63,390, respectively; directors’ remuneration were accrued at $13,430 and $21,130, respectively. The aforementioned amounts were calculated based on the Articles of Incorporation of the Company and recognised in salary expenses.
Employees’ compensation and directors’ remuneration for 2024 amounting to $63,390 and $21,130, respectively, as resolved at the meeting of Board of Directors were in agreement with those amounts recognized in the 2024 financial statements.
Information about employees’ compensation and directors’ remuneration of the Company as resolved at the meeting of Board of Directors will be posted in the “Market Observation Post System” at the website of the Taiwan Stock Exchange.

~48~

(27) Income tax

A. Income tax expense

(a) Components of income tax expense:

The income tax charged to other comprehensive income is as follows:
For the year ended
December31,2025
Current tax:
Income tax arising from current year income
68,425
$ Charge on unappropriated retained earnings
21,498
Prior year income tax underestimation
21,213)
(
Tax paid outside of the territory of
the Republic of China
86,356)
(
Total current tax
17,646)
(
Deferred tax:
Origination and reversal of temporary
differences
29,460

Income tax expense
11,814
$
For the year ended
December31,2025
Translation differences of foreign operations
50,517)
($ Remeasurements of defined benefit plans
812
49,705)
($

For the year ended
December31,2024
20,753
$ 1,048
-
-

21,801
1,727)
(
20,074
$ For the year ended
December 31, 2024
111,531
$ 1,905
113,436
$

(b) The income tax charged to other comprehensive income is as follows:

B. Reconciliation between income tax expense and accounting profit:

			For the year ended			For the year ended
		December31,2025			December31,2024
Tax calculated based on profit before
tax and statutory tax rate		$	77,895		$	67,615
Tax exempt income or expenses disallowed by
tax regulation			12,121			1,443
Tax on unappropriated retained earnings			21,498			1,048
Effect from investment tax credits	(		17,930)	(		9,343)
Prior year income tax underestimation	(		21,213)			-
Tax paid outside of the territory of
the Republic of China	(		86,356)			-
Change in assessment of realisation of
deferred tax assets			25,799	(		40,689)
Income tax expense		$	11,814		$	20,074

~49~

C. Amounts of deferred tax assets or liabilities as a result of temporary differences, tax losses and investment tax credits are as follows:

	January1	Recognised in profit or loss Recognised in other comprehensive income(loss) December 31 471) ($ - $ 13,373 $ - 20,814 20,814 471) ($ 20,814 $ 34,187 $ 28,869) ($ - $ 482,051) ($ - 29,703 - 120) ( 812) ( 6,560) ( 28,989) ($ 28,891 $ 488,611) ($ 29,460) ($ 49,705 $ 454,424) ($ 2025 2024	Recognised in profit or loss Recognised in other comprehensive income(loss) December 31 471) ($ - $ 13,373 $ - 20,814 20,814 471) ($ 20,814 $ 34,187 $ 28,869) ($ - $ 482,051) ($ - 29,703 - 120) ( 812) ( 6,560) ( 28,989) ($ 28,891 $ 488,611) ($ 29,460) ($ 49,705 $ 454,424) ($ 2025 2024
13,844 $ - 13,844 $ 453,182) ($ 29,703) ( 5,628) ( 488,513) ($ 474,669) ($
	January1		Recognised in profit or loss
18,298 $ 81,828 100,126 $ 460,802) ($ - 2,284) ( 463,086) ($ 362,960) ($		4,454) ($ - 4,454) ($ 7,620 $ - 1,439) ( 6,181 $ 1,727 $

~50~

D. Details of the amount the Company is entitled as investment tax credit and unrecognised deferred tax assets are as follows:

==> picture [460 x 55] intentionally omitted <==

----- Start of picture text -----

December 31, 2025
Unrecognized
Qualifying items Unused tax credits deferred tax assets Expiry Year
Research and development $ 1,641 $ 1,641 2026
----- End of picture text -----

December 31 2024: None.

E. Expiration dates of unused tax losses and amounts of unrecognised deferred tax assets are as follows: None.
F. The amounts of deductible temporary difference that are not recognised as deferred tax assets are as follows: None.
G. The Company’s income tax returns through 2022 have been assessed and approved by the Tax Authority.

(28) Earnings per share

Authority. Earnings per share
Basic earnings per share Profit attributable to ordinary shareholders of the parent Diluted earnings per share Profit attributable to ordinary shareholders of the parent Assumed conversion of all dilutive potential ordinary shares Restricted shares to employees Employees’ compensation Profit attributable to ordinary shareholders of the parent plus assumed conversion of all dilutive potential ordinary shares	Amount after tax 377,661 $ 377,661 $ - - 377,661 $ For	Weighted average number of ordinary shares outstanding Earnings per share (share in thousands) (in NT dollars) 305,323 1.24 $ 383 1,421 307,127 1.23 $ theyear ended December 31,2025
			1.24 $
			1.23 $

~51~

For	theyear ended December 31,2024	theyear ended December 31,2024
Amount after tax 318,005 $ 318,005 $ - - 318,005 $	Weighted average number of ordinary shares outstanding (share in thousands) 277,153 1,039 2,111 280,303	Earnings per share (in NT dollars)
		1.15 $
		1.13 $

(29) Supplemental cash flow information Investing activities with partial cash payments

Supplemental cash flow information Investing activities with partial cash payments
Acquisition of property, plant, and equipment Add: Property and equipment and construction billings payable at beginning of year Less: Property and equipment and construction billings payable at end of year ( Cash paid Acquisition of intangible assets Add: Payables at beginning of year Less: Payables at end of year ( Cash paid	For the year ended December31,2025 6,759 $ 2,181 260) ( 8,680 $ For the year ended December31,2025 9,599 $ 159 1,270) ( 8,488 $	For the year ended December31,2024
		10,691 $ 313 2,181)
		8,823 $
		For the year ended December31,2024
		4,949 $ - 159)
		4,790 $

~52~

(30) Changes in liabilities from financing activities

January 1, 2025 Changes in cash flow from financing activities Interest expenses Changes in other non-cash items December 31, 2025 January 1, 2024 Changes in cash flow from financing activities Interest expenses December 31, 2024	Short-term borrowings Short-term notes and bills payable 1,870,000 $ - $ 20,000) ( - - - - - 1,850,000 $ - $ Short-term borrowings Short-term notes and bills payable 1,988,000 $ - $ 118,000) ( 4) ( - 4 1,870,000 $ - $	Short-term notes and bills payable	Long-term borrowings 900,000 $ 723,600) ( - - 176,400 $ Long-term borrowings 900,000 $ - - 900,000 $	Guarantee deposits received	Lease liabilities 83,340 $ 6,002) ( 947 102 78,387 $ Lease liabilities	Total
		- $ - - - - $ Short-term notes and bills payable		6,436 $ 25 - - 6,461 $ Guarantee deposits received		2,859,776 $ 749,577) ( 947 102 2,111,248 $ Total
				6,436 $ - - 6,436 $	89,575 $ 7,250) ( 1,015 83,340 $	2,984,011 $ 125,254) ( 1,019 2,859,776 $

7. RELATED PARTY TRANSACTIONS

(1) Names of related parties and relationship:

LATED PARTY TRANSACTIONS Names of related parties and relationship:
Names of relatedparties	Relationshipwith the Company
Altek International Trading Co., Ltd. (AIT) Altek Lab Inc.(ALI) Altek Semiconductor Corporation (SEMI) Altek Biotechnology Corporation (BIO) Altek Medical Pte. Co., Ltd. Taiwan Branch (AMP-TW) Altek Investment Corporation (AIC) Altek Medical Pte. Ltd. (AMP) Altek Medical Sdn. Bhd. (AMS) Altek Sdn. Bhd. (ASB) Altek (Kunshan) Co., Ltd. (Caltek)	A subsidiary included in the Group's Consolidated Financial Statements (Note) " " " " " " " " "

Note: For information on the Company’s subsidiary, please refer to Note 4(3) in the consolidated financial statements for the year ended December 31, 2025.

~53~

(2) Significant transactions and balances with related parties:

A. Operating revenue:

Year ended December 31, 2025 Sales of Goods: AMP 12,806 $ Other 177 Subtotal 12,983 Sales of services: SEMI 2,616 $ BIO 76,300 Subtotal 78,916 Total 91,899 $	Year ended December 31, 2024 20,428 $ 8 20,436 2,616 $ 55,815 58,431 78,867 $

Goods are sold based on the prices lists in force and terms that would be available to third parties, and the general collection term was 45~90 days after monthly billings.

B. Purchases:

Purchases of Goods: AIT Caltek Other Total	Year ended December 31, 2025 Year ended December 31, 2024 2,096,009 $ 2,191,381 $ 380,004 - 57,386 - 2,533,399 $ 2,191,381 $

Goods are purchased on normal commercial terms and conditions, and the payment terms was 60~120 days after monthly billings.

C. Rent income:

60~120 days after monthly billings. C. Rent income:
SEMI BIO AMP-TW AIC Total		Year ended December 31, 2025		Year ended December 31, 2024
		408 $ 8,068 - 24 8,500 $		408 $ 8,374 540 24 9,346 $

~54~

D. Service fees and other charges:

Year ended December 31, Year ended December 31,

	Year ended December 31,	Year ended December 31,
Receivables from related parties: Payables to related parties: Dividend revenue: SEMI ALI Others Total Accounts receivable: AMS ASB AMP Total SEMI BIO Other Total Other receivables: Accounts payable: AIT Caltek Other Total AIT ALI ASB Caltek SEMI Other Total Other payables: AMP Other Total	2025 1,120 $ 7,076 1,261 9,457 $ December 31,2025 681 $ 501 - 1,182 $ 1,672 $ 39,353 189 41,214 $ December31,2025 116,878 $ 437,281 11,329 565,488 $ - $ 1,405 1,138 757 417 129 3,846 $ December31,2025 722,326 $ 524 722,850 $	2024
		1,092 $ 17,236 1,100 19,428 $ December 31,2024 - $ - 20,680 20,680 $ 2,001 $ 37,185 277 39,463 $ December31,2024 696,595 $ - 445 697,040 $ 1,895 $ 3,011 - - 377 60 5,343 $ December31,2024 287,506 $ - 287,506 $

E. Receivables from related parties:

F. Payables to related parties:

G. Dividend revenue:

AMP Other Total

~55~

(3) Key management compensation

Key management compensation
Salaries and other short-term employee benefits Post-employment benefits Share-based payment compensation costs Total	For the year ended December31,2025 51,186 $ 682 1,842 53,710 $	For the year ended December31,2024 51,848 $ 552 1,874
		54,274 $

8. PLEDGED ASSETS

The Company’s assets pledged as collateral are as follows:

Pledged asset	Book value	Book value
	December 31,2025 206,235 $ 717,201 923,436 $	December 31,2024
Land, buildings and structures Investment property		208,404 $ 723,794
		932,198 $

9. SIGNIFICANT CONTINGENT LIABILITIES AND UNRECOGNISED CONTRACT

COMMITMENTS

None.

10. SIGNIFICANT DISASTER LOSS

None.

11. SIGNIFICANT SUBSEQUENT EVENT

The appropriation of 2025 earnings is provided in Note 6(18).

12. OTHERS

(1) Capital management

The Company’s objectives when managing capital are to safeguard the Company’s ability to continue as a going concern in order to provide returns for shareholders and to maintain an optimal capital structure to reduce the cost of capital. In order to maintain or adjust the capital structure, the Company may adjust the amount of dividends, return capital or issue new shares to achieve the optimal capital structure.

~56~

(2) Financial instruments

A. Financial instruments by category

nancial instruments Financial instruments by category
Financial assets Financial assets measured at fair value through profit or loss Financial assets mandatorily measured at fair value through profit or loss Financial assets at fair value through other comprehensive income Select designated equity instrument investments Financial assets at amortised cost Cash and cash equivalents Accounts receivable (including related parties) Other receivables (including related parties) Guarantee deposits paid Financial liabilities Financial liabilities at amortised cost Short-term borrowings Accounts payable (including related parties) Other payables (including related parties) Long-term borrowings Guarantee deposits received Lease liabilities	December31,2025 72,194 $ - $ 446,859 $ 383,442 48,798 27,248 906,347 $ 1,850,000 $ 601,572 382,092 176,400 6,461 3,016,525 $ 78,387 $	December31,2024
		80,511 $
		- $ 1,105,899 $ 411,786 44,637 25,693
		1,588,015 $
		1,870,000 $ 738,183 369,866 900,000 6,436
		3,884,485 $
		83,340 $

B. Financial risk management policies

(a) The Company’s activities expose it to a variety of financial risks: market risk (including foreign exchange risk, interest rate risk and price risk), credit risk and liquidity risk. To minimize any adverse effects on the financial performance of the Company, derivative financial instruments, such as foreign exchange forward contracts and foreign currency option contracts are used to hedge certain exchange rate risk, and interest rate swaps are used to fix variable future cash flows. Derivatives are used exclusively for hedging purposes and not as trading or speculative instruments.

~57~

(b) Risk management is carried out by a central treasury department (Company treasury) under policies approved by the Board of Directors. Company treasury identifies, evaluates and hedges financial risks in close co-operation with the Company’s operating units. The Board provides written principles for overall risk management, as well as written policies covering specific areas and matters, such as foreign exchange risk, interest rate risk, credit risk, use of derivative financial instruments and non-derivative financial instruments, and investment of excess liquidity.
C. Significant financial risks and degrees of financial risks
(a) Market risk

Foreign exchange risk

i. The Company operates internationally and is exposed to exchange rate risk arising from the transactions of the Company and its subsidiaries used in various functional currency, primarily with respect to the USD. Exchange rate risk arises from future commercial transactions and recognised assets and liabilities.
ii. Exchange rate risk arises when future commercial transactions, recognized assets or liabilities are denominated in a foreign currency that is not the entity's functional currency. The company's management has established a policy to hedge its overall exchange rate risk.
iii. The Company has certain investments in foreign operations, whose net assets are exposed to foreign currency translation risk. Currency exposure arising from the net assets of the Company’s foreign operations is managed primarily through borrowings denominated in the relevant foreign currencies.
iv. The information on assets and liabilities denominated in foreign currencies whose values would be materially affected by the exchange rate fluctuations is as follows:

	December 31,2025	December 31,2025	December 31,2025
Foreign Currency Amount Exchange (In thousands) Rate 21,602 USD 31.430 345,469 USD 31.430 19,222 USD 31.430	Book Value (NTD) 678,951 $ 10,858,090 $ 604,147 $	SensitivityAnalysis
		Effect on Extent of Profit or Variation (Loss) 1% 6,790 $ 1% - $ 1% 6,041) ($	Effect on Other Comprehensive Income(Loss)
			- $ 108,581 $ - $

~58~

December 31, 2024

(Foreign currency: functional currency) Financial assets Monetary items USD:NTD Non-monetary items USD:NTD Financial liabilities Monetary items USD:NTD	Foreign Currency Amount (In thousands) 21,486 USD 341,673 USD 22,614 USD	Exchange Rate 32.785 32.785 32.785	Book Value (NTD) 704,419 $ 11,201,764 $ 741,400 $	Effect on Effect on Other Extent of Profit or Comprehensive Variation (Loss) Income(Loss) 1% 7,044 $ - $ 1% - $ 112,018 $ 1% 7,414) ($ - $ SensitivityAnalysis

v. Total exchange gain including realised and unrealised arising from significant foreign exchange variation on the monetary items held by the Company for the years ended December 31, 2025 and 2024 amounted to $ 8,595 and $11,325, respectively.

Price risk

i. The Company’s equity securities, which are exposed to price risk, are the held financial assets at fair value through profit or loss and financial assets at fair value through other comprehensive income.
ii. The Company’s investments in equity securities comprise shares issued by the domestic companies. The prices of equity securities would change due to the change of the future value of investee companies. If the prices of these equity securities had increased/decreased by 10% with all other variables held constant, post-tax profit for the years ended December 31, 2025 and 2024 would have increased/decreased by $7,219 and $8,051, respectively, as a result of gains/losses on equity securities classified as at fair value through profit or loss. Other components of equity would have increased/decreased by $0 and $0, respectively, as a result of other comprehensive income classified as equity investment at fair value through other comprehensive income.

Cash flow and fair value interest rate risk

The Company's interest rate risk mainly comes from long-term and short-term loans. When the loan interest rate rises or falls by 0.25%, and all other factors remain unchanged, the net profit before tax in 2025 and 2024 will decrease or increase by $5,066 and $6,925, respectively. Mainly due to changes in interest expenses due to borrowings with floating rates.

~59~

(b) Credit risk

i. Credit risk refers to the risk of financial loss to the Company arising from default by the clients or counterparties of financial instruments on the contract obligations. The main factor is that counterparties could not repay in full the accounts receivable based on the agreed terms.
ii. The Company manages their credit risk taking into consideration the entire company’s concern. According to the Company’s credit policy, each local entity in the Company is responsible for managing and analysing the credit risk for each of their new clients before standard payment and delivery terms and conditions are offered. Internal risk control assesses the credit quality of the customers, taking into account their financial position, past experience and other factors. Individual risk limits are set based on internal or external ratings in accordance with limits set by the Board of Directors. The utilisation of credit limits is regularly monitored.
iii. The Company measured internal operating procedures, past experience of trading customers, and actual transaction status. If the contract payments were past due over 90 days based on the terms, there has been a significant increase in credit risk on that instrument since initial recognition. If the contract payments were past due over 360 days based on the term, the default has occurred.
iv. The following indicators are used to determine whether the credit impairment of debt instruments has occurred:
(i) It becomes probable that the issuer will enter bankruptcy or other financial reorganization due to their financial difficulties;
(ii) The disappearance of an active market for that financial asset because of financial difficulties;
(iii) Default or delinquency in interest or principal repayments;
(iv) Adverse changes in national or regional economic conditions that are expected to cause a default.
v. The Company classifies customers’ accounts receivable in accordance with customer types. The Company applies the simplified approach using loss provision matrix to estimate expected credit loss under the provision matrix basis.
vi. The Company wrote-off the financial assets, which cannot be reasonably expected to be recovered, after initiating recourse procedures. However, the Company will continue executing the recourse procedures to secure their rights.

~60~

vii. The Company used the forecastability to adjust historical and timely information to access the default possibility of accounts receivable (included related parties). As of December 31, 2025 and 2024, respectively, the provision matrix is as follows:

December 31,2025 Expected loss rate Total book value Loss allowance December 31, 2024 Expected loss rate Total book value Loss allowance	Up to 90 days past due 91~180 days past due 181 to 360 days past due 0.02% 15% 30% 383,518 $ - $ - $ 76 $ - $ - $ Up to 90 days past due 91~180 days past due 181 to 360 days past due	Over 361 days Total
		100% - $ 383,518 $ - $ 76 $ Over 361 days Total
	0.02% 15% 30% 411,864 $ - $ - $ 78 $ - $ - $	100% - $ 411,864 $ - $ 78 $

viii. Movements in relation to the Company applying the simplified approach to provide loss allowance for accounts receivable (included related parties) are as follows:

At January 1 (Reversal of) impairment loss At December 31	2025 2024 78 $ 353 $ 2) ( 275) ( 76 $ 78 $

(c) Liquidity risk
i. Cash flow forecasting is performed in the operating entities of the Company and aggregated by Company treasury. Company treasury monitors rolling forecasts of the Company’s liquidity requirements to ensure it has sufficient cash to meet operational needs while maintaining sufficient headroom on its undrawn committed borrowing facilities. Such forecasting takes into consideration the Company’s debt financing plans, and compliance with internal balance sheet ratio targets.
ii. Surplus cash held by the operating entities over and above the balance required for working capital management are transferred to the Company treasury. Company treasury invests surplus cash in interest bearing current accounts, time deposits and marketable securities, choosing instruments with appropriate maturities or sufficient liquidity to provide sufficient head-room as determined by the above-mentioned forecasts.

~61~

iii.The Company has the following undrawn borrowing facilities:

0 Fixed rate: Expiring within one year Expiring beyond one year	December 31,2025 2,644,000 $ 823,600 3,467,600 $	December 31,2024 3,424,000 $ 100,000
		3,524,000 $

iv.The table below analyses the Company’s non-derivative financial liabilities into relevant maturity groupings based on the remaining period at the balance sheet date to the contractual maturity date for non-derivative financial liabilities. The amounts disclosed in the table are the contractual undiscounted cash flows.

he table are the contractual undiscounted cash flows.
December 31, 2025 Lessthan 1year 1year to 3 years Non-derivative financial liabilities: Short-term borrowings 1,855,195 $ - $ Accounts payable (including related parties) 601,572 - Other payables (including related parties) 382,092 - Lease liabilities 5,132 8,173 Guarantee deposits received - 6,461 Long-term borrowings - 181,918 December 31, 2024 Lessthan 1year 1year to 3 years Non-derivative financial liabilities: Short-term borrowings 1,874,656 $ - $ Accounts payable (including related parties) 738,183 - Other payables (including related parties) 369,866 - Lease liabilities 5,519 7,577 Guarantee deposits received - 6,436 Long-term borrowings - 928,155	Over3 years
	- $ - - 77,082 - - Over3 years
	- $ - - 83,659 - -

(3) Fair value estimation

A. The different levels that the inputs to valuation techniques are used to measure fair value of financial and non-financial instruments have been defined as follows:
Level 1: Quoted prices (unadjusted) in active markets for identical assets or liabilities that the entity can access at the measurement date. A market is regarded as active where a market in which transactions for the asset or liability take place with sufficient frequency and volume to provide pricing information on an ongoing basis.
Level 2: Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly.

~62~

Level 3: Unobservable inputs for the asset or liability. The fair value of the Company’s investment in equity investment without active market.
B. Fair value information of investment property at cost is provided in Note 6(9).
C. Financial instruments was not measured at fair value, including the carrying amounts of cash and cash equivalents, accounts receivable (included related parties), other receivables (included related parties), deposits paid, short-term borrowings, accounts payable (included related parties), other payables (included related parties), long-term borrowings, deposits received and lease liabilities are approximate to their fair values.
D. The related information of financial and non-financial instruments measured at fair value by level on the basis of the nature, characteristics and risks of the assets and liabilities are as follows:
(a) The related information of nature of the assets is as follows:

December 31, 2025 Assets Recurring fair value measurements Financial assets at fair value through profit or loss Unlisted stocks Financial assets at fair value through other comprehensive income Unlisted stocks December 31, 2024 Assets Recurring fair value measurements Financial assets at fair value through profit or loss Unlisted stocks Financial assets at fair value through other comprehensive income Unlisted stocks	Level 1 - $ - - $ Level 1 - $ - - $	Level 2 - $ - - $ Level 2 - $ - - $	Level 3 72,194 $ - 72,194 $ Level 3 80,511 $ - 80,511 $	Total
				72,194 $ -
				72,194 $
				Total
				80,511 $ -
				80,511 $

~63~

(b) The methods and assumptions the Company used to measure fair value are as follows:
- i. Except for financial instruments with active markets, the fair value of other financial instruments is measured by using valuation techniques. The fair value of financial instruments measured by using valuation techniques can be referred to current fair value of instruments with similar terms and characteristics in substance, discounted cash flow method or other valuation methods, including calculated by applying model using market information available at the consolidated balance sheet date.
ii. The output of valuation model is an estimated value and the valuation technique may not be able to capture all relevant factors of the Company’s financial and non-financial instruments. Therefore, the estimated value derived using valuation model is adjusted accordingly with additional inputs.
E. For the years ended December 31, 2025 and 2024, there was no transfer between Level 1 and Level 2.
F. The following chart is the movement of Level 3 for the years ended December 31, 2025 and 2024:

At January 1 80,511 $ Losses recognised in profit or loss 8,317) ( ( At December 31 72,194 $ 2025	89,789 $ 9,278) 80,511 $ 2024

G. For the years ended December 31, 2025 and 2024, there was no transfer of Level 3.
H. Accounting Department segment is in charge of valuation procedures for fair value measurements being categorised within Level 3, which is to verify independent fair value of financial instruments. Such assessment is to ensure the valuation results are reasonable by applying independent information to make results close to current market conditions, confirming the resource of information is independent, reliable and in line with other resources and represented as the exercisable price, and frequently calibrating valuation model, performing back-testing, updating inputs used to the valuation model and making any other necessary adjustments to the fair value.

~64~

I. The following is the qualitative information of significant unobservable inputs and sensitivity analysis of changes in significant unobservable inputs to valuation model used in Level 3 fair value measurement:

Fair value at December 31, 2025 Financial assets at fair value through profit or loss Unlisted shares 72,194 $ Fair value at December 31, 2024 Financial assets at fair value through profit or loss Unlisted shares 80,511 $	Valuation technique	Significant unobservable input Relationship of inputs to fair value Price to earnings ratio multiple, price to book ratio multiple,discount for lack of marketability, control premium The higher the multiple and control premium, the higher the fair value Significant unobservable input Relationship of inputs to fair value Price to earnings ratio multiple, price to book ratio multiple,discount for lack of marketability, control premium The higher the multiple and control premium, the higher the fair value
	Market comparable companies Valuation technique
	Market comparable companies

13. SUPPLEMENTARY DISCLOSURES

(4) Significant transactions information

A. Loans to others: Please refer to table 1.
B. Provision of endorsements and guarantees to others: None.
C. Holding of significant marketable securities at the end of the period (not including subsidiaries, associates and joint ventures): Please refer to table 2.
D. Purchases or sales of goods from or to related parties reaching NT$100 million or 20% of paidin capital or more: Please refer to table 3.

~65~

E. Receivables from related parties reaching NT$100 million or 20% of paid-in capital or more: Please refer to table 4.
F. Significant inter-company transactions during the reporting periods: Please refer to table 5.
(5) Information on investees
Names, locations and other information of investee companies (not including investees in Mainland China): Please refer to table 6.

(6) Information on investments in Mainland China

A. The related information of investments in Mainland China: Please refer to table 7.
B. Significant transactions, either directly or indirectly through a third area, with investee companies in the Mainland Area: Please refer to table 3 ~ table 5.

14. SEGMENT INFORMATION

Not applicable.

~66~

ALTEK CORPORATION STATEMENT OF CASH AND CASH EQUIVALENTS DECEMBER 31, 2025

(Expressed in thousands of New Taiwan dollars, except as otherwise indicated)

Item Cash Cash on hand -New Taiwan Dollar -Foreign currency USD 5,043.00 at exchange rate of 31.43 Bank deposits Demand deposits Foreign currency demand deposits USD 6,888,865.43 at exchange rate of 31.43 RMB 4,621.83 at exchange rate of 4.4716 JPY 29,644.00 at exchange rate of 0.2008 HKD 1,031.16 at exchange rate of 4.038 EUR 68.91 at exchange rate of 36.9 SGD 80.17 at exchange rate of 24.45 GBP 160.90 at exchange rate of 42.33 Time deposits-Foreign currency (Note) USD 2,500,000.00 at exchange rate of 31.43 Description		Amount
		500 $ 158 658 151,067 216,517 21 6 4 2 2 7 367,626 78,575 446,859 $

Note : Period for the time deposits is 1 to 3 months.

~67~

ALTEK CORPORATION STATEMENT OF ACCOUNTS RECEIVABLES DECEMBER 31, 2025

(Expressed in thousands of New Taiwan dollars, except as otherwise indicated)

Client Name	Description (	Amount 209,694 $ 36,478 28,760 26,057 19,521 61,826 382,336 681 501 1,182 383,518 76) 383,442 $	Note
Customer: A B C D E Other Subtotal Related parties : Altek Medical Pte. Ltd. Altek Sdn. Bhd. Subtotal Total Less : Allowance for uncollectible accounts			The balance of each customer has not exceeded 5% of the accounts receivable

~68~

ALTEK CORPORATION STATEMENT OF INVENTORIES

DECEMBER 31, 2025

(Expressed in thousands of New Taiwan dollars)

Raw material Work in progress Finished goods Less : Allowance for valuation loss Note : Provided in Note 4(12). Item Description		Cost 11,344 $ 38,987 13,051 63,382 13,185) ( 50,197 $	Net Realisable Value 6,185 $ Note 83,282 '' 13,740 '' 103,207 $ Amount Note

~69~

ALTEK CORPORATION

STATEMENT OF CHANGES IN FINANCIAL ASSETS MEASURED AT FAIR VALUE THROUGH PROFIT OR LOSS AND OTHER COMPREHENSIVE INCOME

FOR THE YEAR ENDED DECEMBER 31, 2025

(Expressed in thousands of New Taiwan dollars, except as otherwise indicated)

Book Value Balance	Shares Amount Shares Percentage share holding - 8,317) ($ 762,876 14.55% - - 2 0.00% 8,317) ($ Addition EndingBalance	Book Value	None Note '' Note Collateral
80,511 $ - 80,511 $		72,194 $ - 72,194 $

~70~

ALTEK CORPORATION

STATEMENT OF CHANGES IN INVESTMENTS ACCOUNTED FOR UNDER THE EQUITY METHOD FOR THE YEAR ENDED DECEMBER 31, 2025

(Expressed in thousands of New Taiwan dollars, except as otherwise indicated)

Name	BeginningBalance	BeginningBalance	Shares Amount - 120,699 $ Note 1 - - - - - - - - 120,699 $ Addition	Shares Amount - - $ - 390) ( Note 2 - 38,611) ( Note 1 - 43) ( Note 3 - 425,762) ( Note 4 464,806) ($ Decrease	EndingBalance	EndingBalance	Unit Price Total Amount Collateral Market Value or Net Assets Value	Unit Price Total Amount Collateral Market Value or Net Assets Value
	Shares	Amount	Shares		Shares Percentage of Ownership	Amount
altek International Investment Co., Ltd. Altek Japan Corporation Altek International Holding (BVI) Co., Ltd. Altek Investment Corporation Altek Medical Pte. Ltd.	87,769,559 1,000 12,865,921 10,000,000 45,063,684	8,812,142 $ 9,790 1,427,003 100,583 962,619 11,312,137 $	- - - - -		87,769,559 100.00% 1,000 100.00% 12,865,921 100.00% 10,000,000 100.00% 45,063,684 61.73%	8,932,841 $ 9,400 1,388,392 100,540 536,857 10,968,030 $	- $ - - - -	8,932,841 $ None 9,400 " 1,388,392 " 100,540 " 536,857 " 10,968,030 $

Note 1 : Including the repatriation of earnings, investment gains and losses recognised under the equity method, changes in cumulative conversion adjustments, and the elimination of unrealised gains and losses adjustments for countercurrent transactions between companies, etc.

Note 2 : Including changes in investment gains and losses recognized under the equity method and cumulative conversion adjustments. Note 3 : Investment funds and investment losses recognized under the equity method. Note 4 : It includes changes in income remitted, investment gains and losses recognised under the equity method and accumulated translation adjustments.

~71~

ALTEK CORPORATION STATEMENT OF ACCOUNTS PAYABLES DECEMBER 31, 2025

(Expressed in thousands of New Taiwan dollars, except as otherwise indicated)

==> picture [495 x 227] intentionally omitted <==

----- Start of picture text -----

Client Name Description Amount Note
Non related parties :
The balance of each
payable account has
not exceeded 5% of
Other $ 36,084 the accounts payable
Related parties :
Altek International $ 116,878
Trading Co., Ltd.
Altek (Kunshan) Co., Ltd 437,281
Altek Medical Sdn. Bhd. 17
Altek Sdn. Bhd. 11,312
Subtotal 565,488
Total $ 601,572
----- End of picture text -----

~72~

ALTEK CORPORATION STATEMENT OF SHORT-TERM BORROWINGS DECEMBER 31, 2025

(Expressed in thousands of New Taiwan dollars)

Nature	Description		EndingBalance	Contract Period Range of Interest Rate Expired in 3 months 1.82%~1.89% Expired in 2 years 2.0%~2.1%	Credit Line	Collateral Note None - Yes(Note) -
Unsecured borrowings Secured borrowings	Bank-borrowings Bank-borrowings		1,850,000 $ 176,400 2,026,400 $		4,500,000 $ 1,000,000

Note : The Company's land and buildings on the 1st to 7th floors of Tiding Building in Taipei and its affiliated parking spaces.

~73~

ALTEK CORPORATION STATEMENT OF OPERATING REVENUE FOR THE YEAR ENDED DECEMBER 31, 2025

(Expressed in thousands of New Taiwan dollars)

==> picture [506 x 57] intentionally omitted <==

----- Start of picture text -----

Item Volume Amount Note
Net operating revenue :
AI image-related
application products and services, etc. $ 3,007,608
----- End of picture text -----

~74~

ALTEK CORPORATION STATEMENT OF OPERATING COSTS FOR THE YEAR ENDED DECEMBER 31, 2025

(Expressed in thousands of New Taiwan dollars)

Item

Amount

Direct raw materials used
Raw materials at beginning of year
Add: Raw materials purchased
Raw material surplus
Less: Sale of raw materials
Expenses transferred in
Raw materials at end of year
Consumption of raw materials for the year
Manufacturing expenses
Manufacturing cost
Work in progress at beginning of year
Add: Work in progress purchased
Less: Expenses transferred in
Sales of work in process
Work in progress at end of year
Cost of finished goods
Finished goods at beginning at the year
Add: Finished good purchased
Less: Expenses transferred in
Finished goods at end of year
Total cost of goods sold
Sales of raw materials and work in progress
Allowance of loss on decline in market
Inventory surplus
Repair cost of after-sales service
Other operating costs
Total operating cost

13,558
$ 64,623
2
38,265)
(
1,632)
(
11,344)
(
26,942
21,407
48,349
63,665
273,631
10,911)
(
32,624)
(
38,987)
(
303,123
26,644
2,238,111
2,245)
(
13,051)
(
2,552,582
70,889
722
2)
(
2,253
30,955
2,657,399
$

~75~

ALTEK CORPORATION STATEMENT OF MANUFACTURING EXPENSES FOR THE YEAR ENDED DECEMBER 31, 2025

(Expressed in thousands of New Taiwan dollars, except as otherwise indicated)

==> picture [506 x 170] intentionally omitted <==

----- Start of picture text -----

Item Description Amount Note
Wages and salaries $ 12,377
Import and export expenses 1,198
Outsourcing fees 1,714
Labor and health insurance fees 1,591
Depreciation expense 1,071
The amount of each
item in others does
not exceed 5% of
Other 3,456 the account balance
$ 21,407
----- End of picture text -----

~76~

ALTEK CORPORATION STATEMENT OF SELLING EXPENSES FOR THE YEAR ENDED DECEMBER 31, 2025

(Expressed in thousands of New Taiwan dollars)

Item Description Amount Note Wages and salaries $ 26,678 Import and export expenses 3,031 Cost of materials used 8,350 The amount of each item in others does not exceed 5% of the Other 12,202 account balance $ 50,261

~77~

ALTEK CORPORATION STATEMENT OF ADMINISTRATIVE EXPENSES FOR THE YEAR ENDED DECEMBER 31, 2025

(Expressed in thousands of New Taiwan dollars)

Item Description Amount Note Wages and salaries $ 104,396 Directors' remuneration 18,520 Depreciation charges 19,899 Entertainment expense 14,973 The amount of each item in others does not exceed 5% of the account Other 79,908 balance $ 237,696

~78~

ALTEK CORPORATION STATEMENT OF RESEARCH AND DEVELOPMENT EXPENSES FOR THE YEAR ENDED DECEMBER 31, 2025

(Expressed in thousands of New Taiwan dollars, except as otherwise indicated)

Item Description Wages and salaries Other	Amount Note 247,449 $ 93,223 The amount of each item in others does not exceed 5% of the account balance 340,672 $

~79~

ALTEK CORPORATION

SUMMARY STATEMENT OF CURRENT PERIOD EMPLOYEE BENEFITS, DEPRECIATION, DEPLETION AND AMORTIZATION EXPENSES BY FUNCTION FOR THE YEAR ENDED DECEMBER 31, 2025

(Expressed in thousands of New Taiwan dollars)

==> picture [757 x 142] intentionally omitted <==

----- Start of picture text -----

Function Year ended December 31, 2025 Year ended December 31, 2024
Classified as Operating Classified as Operating Classified as Operating Classified as Operating
Total Total
Nature Costs Expenses Costs Expenses
Employee benefit expense $ 15,270 $ 444,777 $ 460,047 $ 18,077 $ 475,103 $ 493,180
Wages and salaries 12,377 378,523 390,900 14,794 400,255 415,049
Labor and health insurance fees 1,591 25,412 27,003 1,755 25,590 27,345
Pension costs 674 14,854 15,528 766 15,394 16,160
Directors' remuneration - 18,520 18,520 - 26,220 26,220
Other personnel expenses 628 7,468 8,096 762 7,644 8,406
Depreciation charges 1,071 43,661 44,732 1,233 44,853 46,086
Amortisation charges - 5,807 5,807 - 3,888 3,888
----- End of picture text -----

Note:

As at December 31, 2025 and 2024, the Company had 234 and 248 employees, including 6 non-employee directors.
Average employee benefit expense in current year and previous year is $1,937 and $1,930, respectively. (Total employee benefits- directors' remuneration / number of employees - number of non-emplyee directors )
Average employees salaries in current year and previous year is $1,714 and $1,715, respectively. (Total employee salaries / number of employees - number of non-emplyee directors )
Adjustments of average employees salaries -0.1%. (Average employee salaries current year - Average employee salaries previous year / Average employee salaries previous year )
The supervisors’ remuneration for the years ended December 31, 2025 and 2024 were both $0, due to the establishment of the audit committee.
The Company’s policies of salary and remuneration were as follows:

The Company’s compensation for directors including directors’ return, traveling expenses and directors’ remuneration. In accordance with the Company’s Articles of Incorporation, directors’ return

was based on the degree of participant in the operation, value of contribution to the Company and common standard of the industry. Traveling expenses were based on the common standard of

the industry and the attendance of the Board of Directors. Directors’remuneration shall not be higher than 5% of the profit of current year.

The Company's compensation for managers and employees including salary, award and employees’ return were based on the contribution, experience, management performance and responsibility and referred to the standard of the same industry. Managers’ performance examination and salary and remuneration have been reviewed by the remuneration committee and the Board of Directors, and will be checked based on the actual management result and related laws accordingly. Additionally, in accordance with the Company’s Articles of Incorporation, employees’compensation shall be distributed based on 5% to 20% of the profit of the current year, with no less than 15% of this amount allocated to

rank-and-file employees.

~80~

Table 1

Altek Corporation Loans to other For the year ended December 31, 2025

Expressed in thousands of NTD (Except as otherwise indicated)

No.	Creditor	Borrower	General ledger account	Is a related party	Maximum outstanding balance during the year ended December 31, 2025	Balance at December 31, 2025	Actual amount drawn down	Interest rate	Nature of loan	Amount of transactions with the borrower	Reason term financing	Allowance for doubtful accounts	Collateral	Limit on loans granted to a singleparty	Ceiling on total loans granted
													Item Value
1 2 3	Altek (Kunshan) Co., Ltd. Altek International Holding (BVI) Co., Ltd. altek International Investment Co., Ltd.	Altek Optical Technology (Kunshan) Co. , Ltd. Altek Medical Pte. Ltd. Altek Medical Pte. Ltd.	Other receivables- related party Other receivables- related party Other receivables- related party	Yes Yes Yes	46,258 $ 398,460 188,580	44,716 $ 188,580 188,580	44,716 $ 188,580 188,580	2.50% 0% 0%	Reason for short-term financing Reason for short-term financing Reason for short-term financing	- - -	Operational need Operational need Operational need	- - -	N/A - N/A - N/A -	817,329 $ 416,477 1,787,677	1,634,658 $ 1,388,257 8,938,384

Note 1: If the amount of NTD in this Note relates to foreign currencies, it is converted to NTD at the exchange rate at the end of the financial reporting period. Note 2: The ”Procedure for Provision of Loans” policy for loans granted by Altek (Kunshan) Co., Ltd. is as follows: the ceiling on total loans is 40% of the net assets value of lender. For a single enterprise, the ceiling on loans is 20% of the net assets value of lender.

Note 3: The ”Procedure for Provision of Loans” policy for loans granted by Altek International Holding (BVI) Co., Ltd. is as follows: the ceiling on total loans is 100% of the net assets value of lender. For a single enterprise, the ceiling on loans is 30% of the net assets value of lender.

Note 4: The ”Procedure for Provision of Loans” policy for loans granted by altek International Investment Co., Ltd. is as follows: the ceiling on total loans is 100% of the net assets value of lender. For a single enterprise, the ceiling on loans is 20% of the net assets value of lender.

Table 1

Altek Corporation

Holding of significant marketable securities at the end of the period (not including subsidiaries, associates and joint ventures)

December 31, 2025

			December 31, 2025
Table 2 Securities held by	Marketable securities	Relationship with the securities issuer	General ledger account		As of December 31,2025 Expressed in thousands of NTD (Except as otherwise indicated)
				Numberofshares (units)	Bookvalue	Ownership (%)	Fairvalue
Altek Corporation Altek Medical Pte. Ltd. Altek (Kunshan) Co., Ltd. altek International Investment Co., Ltd. " " " "	Gianta Co., Ltd. - Common stock Profusa, Inc. - Common stock CPEC Huachuang Private Equity (Kunshan) Enterprise (Limited Partnership) Apple Inc.-Corporate bond Microsoft Corp-Corporate bond Procter & Gamble Company-Corporate bond HSBC Holding Plc-Financial Bonds UBS Group AG-Financial Bonds	Director None None None None None None None	Financial assets at fair value through profit or loss - non-current Financial assets at fair value through other comprehensive income- non-current " Financial assets at amortised cost - non-current " " " "	762,876 323,834 N/A N/A N/A N/A N/A N/A	72,194 1,018 38,636 94,110 93,284 92,286 72,710 75,954	14.55% 0.767% 1.00% N/A N/A N/A N/A N/A	72,194 1,018 38,636 94,110 93,284 92,286 72,710 75,954

Table 2

Altek Corporation

Purchases or sales of goods from or to related parties reaching NT$100 million or 20% of paid-in capital or more

For the year ended December 31, 2025

			For	the year ended December 31, 2025	the year ended December 31, 2025
Table 3 Purchaser/seller	Counterparty	Relationship with the counterparty		Transaction			Differences in transaction terms compared to third party transactions		Notes/accounts receivable(payable) Expressed in thousands of NTD (Except as otherwise indicated)
			Purchases (sales)	Amount	Percentage of total purchases (sales)	Credit term	Unitprice	Credit term	Balance	Percentage of total notes/accounts receivable (payable)
Altek Corporation Altek Corporation Altek International Trading Co., Ltd. Altek Biotechnology Corporation Altek Biotechnology Corporation Altek Sdn. Bhd. Altek Medical Pte. Ltd. Altek Medical Pte. Ltd. Altek Medical Pte. Ltd. Altek Medical (Kunshan) Limited Altek Medical Sdn. Bhd.	Altek International Trading Co., Ltd. Altek (Kunshan) Co., Ltd. Altek (Kunshan) Co., Ltd. Altek Medical (Kunshan) Limited Altek Medical Sdn. Bhd. Altek (Kunshan) Co., Ltd. Altek Biotechnology Corporation Altek Medical (Kunshan) Limited Altek Medical Sdn. Bhd. Altek (Kunshan) Co., Ltd. Altek Medical (Kunshan) Limited	Parent-subsidiary Parent-subsidiary The same ultimate parent company The same parent company The same parent company The same ultimate parent company Parent-subsidiary Parent-subsidiary Parent-subsidiary The same ultimate parent company The same parent company	Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases	2,096,009 $ 380,004 2,133,162 1,566,152 439,996 192,631 2,407,372 723,790 442,565 181,086 362,481	81% 15% 100% 78% 22% 88% 66% 20% 12% 7% 41%	Net 120 days Net 75 days " " " " " " " " "	Approximately the same price with third parties " " " " " " " " " "	Note " " " " " " " " " "	116,878) ($ 437,281) ( - 130,292) ( 44,784) ( 146,229) ( 157,989) ( 55,908) ( 16,671) ( 68,353) ( 97,599) (	19% 73% 0% 73% 25% 89% 52% 19% 6% 12% 32%

Note: The payment term with third parties was net 60~120 days.

Table 3

Altek Corporation

Receivables from related parties reaching NT$100 million or 20% of paid-in capital or more

December 31, 2025

Table 4

Expressed in thousands of NTD (Except as otherwise indicated)

Creditor	Counterparty	Relationship with the counterparty	Balance as at December 31,2025	Turnover rate	Overdue receivables	Overdue receivables	Amount collected subsequent to the balance sheet date	Allowance for doubtful accounts	Note
					Amount	Action taken
Altek International Trading Co., Ltd. Altek (Kunshan) Co., Ltd. Altek Medical (Kunshan) Limited. Altek (Kunshan) Co., Ltd. Altek Biotechnology Corporation Altek International Holding (BVI) Co., Ltd. altek International Investment Co., Ltd.	Altek Corporation Altek Corporation Altek Biotechnology Corporation Altek Sdn. Bhd. Altek Medical Pte. Ltd. Altek Medical Pte. Ltd. Altek Medical Pte. Ltd.	Parent-subsidiary Parent-subsidiary The same ultimate parent company The same ultimate parent company Parent-subsidiary The same ultimate parent company The same ultimate parent company	116,878 $ 437,281 130,292 146,229 157,989 188,580 188,580	4.66 7.88 7.78 3.44 10.92 - -	- $ - - - - - -	N/A N/A N/A N/A N/A N/A N/A	31,435 $ 350,987 121,711 60,185 157,989 - 94,290	- $ - - - - - -	Note Note

Note: These represent loans of funds to related parties and are recorded under other receivables.

Table 4

Table 5

Altek Corporation

Significant inter-company transactions during the reporting periods

For the year ended December 31, 2025

Expressed in thousands of NTD

(Except as otherwise indicated)

Transaction

					Transaction
Companyname	Counterparty	Relationship (Note 1)	General ledgeraccount	Amount	Transaction terms	Percentage of consolidated total operating revenues or totalassets (Note2)
Altek Corporation " " " " Altek International Trading Co., Ltd. Altek Biotechnology Corporation " " " Altek (Kunshan) Co., Ltd. " Altek Sdn. Bhd. " Altek Medical Pte. Ltd. " " " " " " Altek Medical (Kunshan) Limited " Altek Medical Sdn. Bhd. " " " Altek (Kunshan) Co., Ltd. Altek International Holding (BVI) Co., Ltd. altek International Investment Co., Ltd.	Altek International Trading Co., Ltd. " Altek (Kunshan) Co., Ltd. " Altek Sdn. Bhd. Altek (Kunshan) Co., Ltd. Altek Medical (Kunshan) Limited " Altek Medical Sdn. Bhd. " Altek International Trading Co., Ltd. Altek Optical Technology (Kunshan) Co. , Ltd Altek (Kunshan) Co., Ltd. " Altek Biotechnology Corporation " Altek Medical (Kunshan) Limited " Altek Medical Sdn. Bhd. Altek Sdn. Bhd. " Altek (Kunshan) Co., Ltd. " " " Altek Medical (Kunshan) Limited " Altek Optical Technology (Kunshan) Co. , Ltd Altek Medical Pte. Ltd. "	(1) (1) (1) (3) (3) (3) (3) (3) (3) (3) (3) (3) (3) (3) (3) (3) (3) (3) (3) (3) (3) (3) (3) (3) (3) (3) (3) (3) (3) (3)	Purchases Accounts payable Purchases Accounts payable Purchases Purchases Purchases Accounts payable Purchases Accounts payable Purchases Accounts payable Purchases Accounts payable Purchases Accounts payable Purchases Accounts payable Purchases Purchases Accounts payable Purchases Accounts payable Purchases Accounts payable Purchases Accounts payable Other receivables Other receivables Other receivables	2,096,009 $ 116,878 380,004 437,281 57,360 2,133,162 1,566,152 130,292 439,996 44,784 25,938 44,716 192,631 146,229 2,407,372 157,989 723,790 55,908 442,565 70,458 71,010 181,086 68,353 91,748 26,281 362,481 97,599 44,716 188,580 188,580	Net 120 days " Net 75 days " " " " " " " " " " " " " " " " " " " " " " " " Scheduled payments and receipts " "	24% 1% 4% 3% 1% 25% 18% 1% 5% 0% 0% 0% 2% 1% 28% 1% 8% 0% 5% 1% 0% 2% 0% 1% 0% 4% 1% 0% 1% 1%

Note 1: Relationship between transaction and counterparty is classified into the following categories:

(1) Parent company to subsidiary.
(2) Subsidiary to parent company.

(3) Subsidiary to subsidiary.

Note 2: Regarding percentage of transaction amount to consolidated total operating revenues or total assets, it is computed based on period-end balance of transaction to consolidated total assets for balance sheet accounts and based on accumulated transaction amount for the period to consolidated total operating revenues for income statement accounts.

Note 3: The Company may decide to disclose or not to disclose transaction details in this table based on the Materiality Principle.

Table 5

Altek Corporation

Table 6

Expressed in thousands of NTD (Except as otherwise indicated)

Names, locations and other information of investee companies (not including investees in Mainland China)

For the year ended December 31, 2025

Investor	Investee	Location	Main business activities	Initial invest	ment amount	Shares he	ld as at December	31,2025	Net profit (loss) of the investee for the year ended December 31,2025	Investment income(loss) recognised by the Company for the year ended December 31,2025	Footnote
				Balance as at December 31, 2025	Balance as at December 31, 2024	Number of shares	Ownership (%)	Book value
Altek Corporation " " " " altek International Investment Co., Ltd. " " " Altek Semiconductor (Cayman) Co., Ltd. Altek Medical Pte. Ltd. " " Altek (Kunshan) Co., Ltd. Altek International Holding (BVI) Co., Ltd. Altek Pte. Ltd.	altek International Investment Co., Ltd. Altek Japan Corporation Altek International Holding (BVI) Co, Ltd. Altek Investment Corporation Altek Medical Pte. Ltd. Altek Lab Inc. Altek Semiconductor (Cayman) Co., Ltd. Altek Optical Technology (Cayman) Co., Ltd. Altek International Trading Co,. Ltd. Altek Semiconductor Corporation Altek Biotechnology Corporation Altek Medical (HongKong) Limited Altek Medical Sdn. Bhd. Altek Technology Co., Ltd. Altek Pte. Ltd. Altek Sdn. Bhd.	British Virgin Islands Japan British Virgin Islands Republic of China Singapore U.S.A. Cayman Islands Cayman Islands Republic of Seychelles Republic of China Republic of China HongKong Malaysia Republic of China Singapore Malaysia	Investment Buying and selling of electronic components Investment Investment Research and development, sales of medical electronic equipment and investment Collection of American digital imaging technology information and design services Investment Investment Intercompany transactions Research design and sales of ASIC Research and development, manufacture and sales of medical electronic equipments Investment Production services for medical electronic equipments Production and sales of electronic related product components Investment Production services for digital imaging application	$ 2,886,407 2,869 415,376 100,000 755,272 115,654 419,503 416,322 314,300 500,000 25,376 47,145 157,150 28,000 172,865 157,150	2,886,407 $ 2,869 415,376 100,000 755,272 115,654 419,503 416,322 314,300 500,000 25,376 47,145 125,720 28,000 - -	87,769,559 1,000 12,865,921 10,000,000 45,063,684 11,311,875 43,000,000 13,246,000 10,000,000 50,000,000 1,100,000 N/A 22,732,000 2,800,000 5,500,000 20,820,000	100 100 100 100 61.73 100 100 100 100 100 100 100 100 100 100 100	8,932,841 $ 9,400 1,388,392 100,540 536,857 69,668 250,215 193,483 211,540 243,108 1,037,376 124,735 143,592 28,156 168,634 153,111	332,738 $ 36 16,468 482 480,772 816 127,704 45,098 13,577) ( 127,640 74,206 19,532 277) ( 137 7,805) ( 7,614) (	332,818 $ 36 16,602 482 320,617 816 129,206 45,098 13,577) ( 127,640 49,451 13,159 1,125 137 7,805) ( 7,614) (	Note 1 Note 1 Note 1 Note 1 Note 1 Note 2 Note 3

Note 1: The difference between the profit or loss of the investee for the current period and the investment profit or loss recognized in the current period is the unrealized profit and loss adjustments for countercurrent transactions between subsidiaries. Note 2: It was established by Altek International Holding (BVI) Co., Ltd. at May 2025.

Note 3: It was established by Altek Pte. Ltd. at May 2025.

Table 6

Altek Corporation Information on investments in Mainland China For the year ended December 31, 2025

Expressed in thousands of NTD (Except as otherwise indicated)

Table 7

Investee in Mainland China	Main business activities	Paid-in capital	Investment method `（`Note 1`）`	Accumulated amount of remittance from Taiwan to Mainland China as of January1, 2025	Amount remitted from Taiwan to Mainland China/Amount remitted back to Taiwan for the year ended December 31, 2025	Accumulated amount of remittance from Taiwan to Mainland China as of December 31, 2025	Net profit (loss) of investee for the year ended December 31, 2025	Ownership held by the Company (direct or indirect)	Investment income (loss) recognised by the Company for the year ended December 31, 2025	Accumulated amount of investment income remitted back to Taiwan as of December 31, 2025 Book value of investments in Mainland China as of December 31, 2025
					Remitted to Mainland China Remitted back to Taiwan
Altek (Kunshan) Co., Ltd. (Note 2) Toptek Electronics (Kunshan) Co., Ltd. (Note 3 ) Altek Trading (Shanghai) Co., Ltd. Altek Precision(Kunshan) Co., Ltd. Altek Optical Technology(Kunshan) Co., Ltd. Altek Semiconductor(Shanghai) Co., Ltd. Altek Medical(Shanghai) Limited Altek Medical(Kunshan) Limited Jia Jing Business Management (Kunshan) Co., Ltd. (Note 5) Hong Jing Business Management (Kunshan) Co., Ltd. (Note 5)	Production service for digital imaging application Production /sales of electronic product components Wholesale and import/export of electronic products and accessories and package products Production/sales of plastic and mental parts Manufacture and sale of components for electronic related products Research design and sales of imaging technologies, electronic software and hardware Sales of medical electronic equipment Production service for medical electronic equipment Business management and non-residential real estate leasing Business management, housing leasing and property management	554,111 $ 157,150 267,155 433,734 440,020 47,145 31,430 26,830 594,656 410,162	2 2 2 2 2 2 2 2 2 2	409,533 $ 285,479 267,155 433,734 418,019 - - - 594,656 410,161	- $ - $ - - - - - - - - - - - - - - - - - -	409,533 $ 285,479 267,155 433,734 418,019 - - - 594,656 410,161	135,935 $ 9,579 3,406) ( 2,385 60,131 2,874) ( 19,719 41,161 41,988 12,483) (	100 100 100 100 75 100 61.73 61.73 100 100	135,935 $ 9,579 3,406) ( 2,385 45,098 2,874) ( 13,281 27,592 41,988 12,483) (	4,086,646 $ - $ 584,698 94,290 260,021 - 169,951 - 193,480 - 98,690 - 121,843 - 110,108 - 732,459 - 421,944 -

Note 1: Investment methods are classified into the following three categories; fill in the number of category each case belongs to: (1)Directly invest in a company in Mainland China.

(2)Through investing in an existing company in the third area,which then investeed in the investee in Mainland China. (3)Others.

Note 2: Including retained earnings capitalized of US$4,600 (In thousand of US dollars). Note 3: Including retained earnings capitalized of US$3,600 (In thousand of US dollars). Note 4: Investment income or loss was recognised in the financial statements that are audited by the R.O.C parent company's independent auditors. Note 5: It was established by Altek (Kunshan) Co., Ltd.

Companyname	Accumulated amount of remittance from Taiwan to Mainland China as of December 31, 2025	Investment amount approved by the Investment Commission of the Ministryof Economic Affairs(MOEA)	Ceiling on investments in Mainland China imposed bythe Investment Commission of MOEA
Altek Corporation	$2,818,737	$3,148,458	$5,992,809

Table 7

AI assistant

Altek — Audit Report / Information 2025

52290_rns_2025-11-14_5f1d1390-735e-43bd-af5b-1593a2af6f2e.pdf

ALTEK CORPORATION

PARENT COMPANY ONLY FINANCIAL

STATEMENTS AND INDEPENDENT AUDITORS’

Opinion

Basis for opinion

Key audit matters

Allowance for inventory valuation losses

Description

How our audit addressed the matter

Responsibilities of management and those charged with governance for the parent company only financial statements

Auditor’s responsibilities for the audit of the parent company only financial

statements

[Hsieh, Chih-Cheng ]

ALTEK CORPORATION

PARENT COMPANY ONLY BALANCE SHEETS DECEMBER 31, 2025 AND 2024

ALTEK CORPORATION

PARENT COMPANY ONLY BALANCE SHEETS DECEMBER 31, 2025 AND 2024

ALTEK CORPORATION

PARENT COMPANY ONLY STATEMENTS OF COMPREHENSIVE INCOME YEARS ENDED DECEMBER 31, 2025 AND 2024

ALTEK CORPORATION

PARENT COMPANY ONLY STATEMENTS OF CHANGES IN EQUITY YEARS ENDED DECEMBER 31, 2025 AND 2024

ALTEK CORPORATION

PARENT COMPANY ONLY STATEMENTS OF CASH FLOWS YEARS ENDED DECEMBER 31, 2025 AND 2024

ALTEK CORPORATION

PARENT COMPANY ONLY STATEMENTS OF CASH FLOWS YEARS ENDED DECEMBER 31, 2025 AND 2024

ALTEK CORPORATION NOTES TO THE PARENT COMPANY ONLY FINANCIAL STATEMENTS DECEMBER 31, 2025 AND 2024

1. HISTORY AND ORGANISATION

PROCEDURES FOR AUTHORISATION

3. APPLICATION OF NEW STANDARDS, AMENDMENTS AND INTERPRETATIONS

not yet adopted by the Company

4. SUMMARY OF MATERIAL ACCOUNTING POLICIES

(1) Compliance statement

(3) Foreign currency translation

(4) Classification of current and non-current items

(5) Cash equivalents

(6) Financial assets at fair value through profit or loss

(10) Derecognition of financial assets

(13) Investments accounted for using equity method / associates

(14) Property, plant and equipment

(16) Investment property

(17) Intangible assets

(18) Impairment of non-financial assets

(19) Borrowings

(20) Accounts payable

(21) Provisions

(22) Employee benefits

B. Pensions

(a) Defined contribution plans

(b) Defined benefit plans

- (23) Employee share based payment

(24) Income tax

(25) Share capital

(26) Dividends

(27) Revenue recognition

(2) Critical accounting estimates and assumptions

6. DETAILS OF SIGNIFICANT ACCOUNTS

(1) Cash and cash equivalents

(2) Financial assets at fair value through profit or loss

(3) Financial assets at fair value through other comprehensive income

(4) Accounts receivable

(5) Inventories

(7) Property, plant and equipment

2024

－ (8) Leasing arrangements lessee

G. Extension and termination options

(9) Investment property

(10) Intangible assets

(11) Short-term borrowings

- (12) Long term borrowings

(13) Pensions

December 31, 2025

(14) Share-based payment

(16) Share capital

(17) Capital surplus

(18) Retained earnings

F. The appropriation of 2025 earnings had been resolved at the shareholders’ meeting on March 11, 2026. Details are summarised below:

(19) Other equity items

Altek Audit Report / Information 2025

`－` (8) Leasing arrangements lessee